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ABSTRACT 
The sale of small turtles is banned from the US market due to concerns about their 
excretion of Salmonella spp. To produce a safe pet for the export market, the Louisiana pet 
turtle industry uses 1000 µg/ml gentamicin sulfate baths to eradicate Salmonella spp. from 
turtle eggs. In 1999, we analyzed bacterial samples recovered from turtle farms and found that 
strains of Salmonella enterica subsp. arizonae and other bacteria such as Salmonella enterica 
subsp. enterica, Enterobacter cloacae, Citrobacter freundii, Pseudomonas aeruginosa and 
Stenotrophomonas maltophilia, were resistant to high concentrations of gentamicin (>2000 
µg/ml) and to other aminoglycosides. The goal of this study was to identify the gene(s) 
contributing to the high-level gentamicin resistance phenotype observed in bacteria from 
environmental samples with turtle farming activity, particularly the salmonellae, and to 
estimate their incidence in these bacteria, as well as to explore the molecular elements that 
contribute to the dissemination of gentamicin resistance in this context. R-plasmids from 
gentamicin resistant strains were transferred by conjugation and transformation to naïve 
Escherichia coli cells. Cloning and sequencing of the gentamicin resistance determinants on 
these plasmids revealed the presence of aminoglycoside acetyltransferase genes aac(3)IIa and 
aac(3)VIa. Multiplex PCR assays showed that every gentamicin resistant isolate carried either 
one of these acetyltransferase genes. Pulsed-Field Gel Electrophoresis and restriction enzyme 
digestion analysis of R-plasmids carrying these genes revealed plasmids with sizes ranging 
from ca. 45 kb to 145 kb, with different restriction profiles, supporting their presence on mobile 
molecular elements. In effect, gene aac(3)VIa was present as a gene cassette of a class 1 
integron. Furthermore, evidence suggests that gene aac(3)IIa may be encoded as part of a 
complex class 1 integron. The presence of aac(3)IIa and aac(3)VIa in mobile molecular 
elements explains the distribution of these genes in the different plasmids and organisms 
 xiii
described in this study. Further studies are required to characterize these molecular elements, 
and to detect genes which may be co-selected in the presence of gentamicin. This work is one 
of the first to report dissemination of high-level gentamicin resistance in Gram-negative 
bacteria, particularly in environmental isolates of Salmonella enterica subsp. arizonae.  
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CHAPTER 1:  INTRODUCTION 
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1.1  Background - Gentamicin Resistance in Louisiana Pet Turtle Farms 
The pet turtle industry began in the 1930s, with the sale of hatchlings in the United States 
pet market. In 1974, the sale of baby turtles was banned by the Food and Drug Administration 
(FDA) in the domestic market due to concerns about their excretion of the human pathogen 
Salmonella spp., etiological agent of Salmonellosis or “Salmonella food poisoning” (Siebeling, 
R.J., et al, 1975b; Cohen, M.L., et al, 1980; Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 
1984; Izadjoo, M.J., et al, 1987; D'Aoust, J.Y., et al, 1990; Shane, S.M., et al, 1990; Ebani, V.V., 
et al, 2005). In spite of the domestic ban on the sale of small carapace turtles, the export market 
has continued to thrive. Thus, around 12 million hatchlings enter the export market each year to 
Western Europe, South America and Asia (Japan, China). The economic impact of the industry 
in the State of Louisiana is estimated around 30 million US dollars. The main geographical areas 
in Louisiana where turtle farming occurs are Pierre Part, Jonesville and Ponchatoula (Figure 1.1) 
(Siebeling, R.J., et al, 1975b; Siebeling, R.J., et al, 1975a; Michael-Marler, S., et al, 1983; 
Siebeling, R.J., et al, 1984).   
In order to eradicate Salmonella spp. from turtle eggs, farmers follow a modified version 
of the protocol used in the turkey industry to treat eggs, the pressure-differential egg-dip 
procedure (Saif, Y.M. and Shelly, S.M., 1973; Greenfield, J., et al, 1975; Nivas, S.C., et al, 
1975; Ekperigin, H.E. and McCapes, R.H., 1977; Ekperigin, H.E., et al, 1983). This modified, 
FDA-approved treatment is summarized as follows: 1) Every day from April through September, 
eggs are picked from fresh nests; at this point each egg harbors approximately 10-75 million 
bacteria (Siebeling, R.J., et al, 1984). 2) Eggs are immersed in a Clorox bath at 380 ppm (1 
oz/gallon) for 10-15 min.; this sanitation step reduces bacterial counts to 10-50,000 per egg 
(Siebeling, R.J., et al, 1984). 3) Sanitized eggs are treated in baths of gentamicin sulfate 
(Garasol; Shering Corp., Bloomfield, N.J.), at 1000 ppm (1000 µg/ml), using the pressure-
 2
differential method (Siebeling, R.J., et al, 1975b; Michael-Marler, S., et al, 1983; Siebeling, R.J., 
et al, 1984). It is mandatory in the State of Louisiana to treat eggs with this antibiotic in order to 
eradicate Salmonella spp. Gentamicin sulfate was chosen for the treatment of turtle eggs since it 
presents various advantages at a commercial turtle farm; notably, it does not lose its 
 
 
 
 
 
Figure 1.1:  Distribution of Pet Turtle Farms in Louisiana 
 
 
 
antimicrobial activity when in solution or when exposed to freezing or auto-claving 
temperatures, allowing it to be reused after appropriate readjustments are made (Michael-Marler, 
S., et al, 1983; Siebeling, R.J., et al, 1984). 4) After a 60 day incubation period, turtles hatch, and 
before they can be exported, representative samples from each farm must be tested for 
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Salmonella spp. This test, called “Certification”, is done by independent FDA-certified 
laboratories; it involves the enrichment, isolation, and identification of Salmonella spp. through 
classic bacteriological and molecular assays (Siebeling, R.J., et al, 1975a; Michael-Marler, S., et 
al, 1983; Siebeling, R.J., et al, 1984).  
S. enterica subsp. enterica serovar Enteritidis is the major cause of Salmonella food 
poisoning in the U.S., since it is a frequent contaminant of chicken eggs (Cohen, M.L., et al, 
1980; Carattoli, A., 2003). Salmonella spp. is a mesophilic, Gram-negative, motile bacillus, 
bacteriologically characterized as a non-lactose fermentor, H2S-positive, lysine-decarboxylase-
positive microorganism. S. enterica subsp. arizonae, which commonly inhabits the cloacae of 
reptiles, can be readily differentiated bacteriologically from other salmonellae since it is a 
delayed lactose fermentor (Siebeling, R.J., et al, 1975a; Siebeling, R.J., et al, 1984; Ebani, V.V., 
et al, 2005).  
It is well known that the use of any antibiotic presents a life cycle where resistance to the 
particular antibiotic will generally follow its implementation or use (Davies, J. and Smith, D.I., 
1978; Levy, S.B., 1998; Mazel, D. and Davies, J., 1999; Levy, S.B., 2002). Gentamicin 
resistance in Salmonella spp. isolated from pet turtles was originally reported in Canada, in 1990, 
a study stating that turtles exported from Louisiana to Canada carried gentamicin-resistant 
Salmonella spp. (D'Aoust, J.Y., et al, 1990). Concerns of the emergence of gentamicin-resistant 
S. enterica subsp. arizonae, which could survive gentamicin treatment, had been previously 
reported in the turkey industry (Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). This 
gentamicin resistance problem was later addressed at L.S.U. in collaborative work between the 
laboratories of E.C. Achberger, and R.J. Siebeling (Jenson, M.A.B., 1992). This work falls under 
the umbrella of such collaboration (Diaz, M.A., et al, in press). 
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In July of 1999, 11 of 16 turtle farms in Pierre Part had shipment lots fail certification. 
Bacterial isolates were obtained for further studies from failed-lot turtle samples provided by the 
Central Analytical Laboratories, Belle Chase, LA. Identification by standard bacteriological 
assays and by API-20E (bioMérieux SA, Marcy l'Etoile, France) confirmed the presence of S. 
enterica subsp. arizonae. All isolates tested were resistant to concentrations of gentamicin >2000 
µg/ml, which is higher than the concentration used to treat the eggs. Other bacteria, such as 
Enterobacter cloacae, Citrobacter freundii, Stenotrophomonas maltophilia and Pseudomonas 
aeruginosa, among others, were also found to have this level of gentamicin resistance. We 
became interested in studying the high-level gentamicin resistance expressed by these bacteria 
since this resistance had not been reported in Gram-negative bacteria (Diaz, M.A., et al, 2000). 
1.2  Aminoglycoside Antibiotics 
Antibiotics are biochemical compounds produced by microorganisms which can inhibit the 
growth or kill other microorganisms (Levy, S.B., 1998). They act selectively on prokaryotic 
targets, which can be the bacterial cell wall, cell membrane function, nucleic acid synthesis, 
protein synthesis or other bacterial enzymatic pathways (Levy, S.B., 1998; Mazel, D. and 
Davies, J., 1999).  Aminoglycoside antibiotics act by inhibiting prokaryotic protein synthesis 
(Davis, B.D., 1987; Wright, G.D., et al, 1998; Azucena, E. and Mobashery, S., 2001; Vakulenko, 
S.B. and Mobashery, S., 2003).  
Aminoglycosides are produced by the Actinomycetes Streptomyces spp. (i.e. neomycin, 
kanamycin and tobramycin) and Micromonospora spp. (i.e. gentamicin and sisomicin). 
Gentamicin is produced by Micromonospora purpurea. There are also semisynthetic members of 
the family, which are created by chemical modification of the original molecules, i.e. amikacin 
and netilmicin (Davis, B.D., 1987; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, 
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S., 2003). The first aminoglycoside, streptomycin, was discovered in 1944 by Waksman, from 
Streptomyces griseus (Waksman, S.A., 1958; Comroe, J.H., Jr., 1978).   
Aminoglycosides consist of an aminocyclitol ring, 2-deoxystreptamine, or streptidine in 
the case of streptomycin, which is joined by glycosidic bonds to two or more aminosugars 
(Wright, G.D., et al, 1998). They are highly polar molecules of a relatively large size. The two 
major classes of 2-deoxystreptamine aminoglycosides are the 4,5-disubstituted neomycin, 
paramomycin, and ribostamycin, and the 4,6-disubstituted gentamicins and kanamycins. 
Gentamicin, as well as kanamycin and amikacin, belong to the 4,6-disubstituted class of the 2-
deoxystreptamine aminoglycosides (Figure 1.2) (Davis, B.D., 1987; Wright, G.D., et al, 1998; 
Vakulenko, S.B. and Mobashery, S., 2003).  
1.2.1. Clinical Use 
Aminoglycosides are highly-potent, broad-spectrum, bactericidal antibiotics that can be 
used both on Gram-positive and Gram-negative bacteria (Moore, R.D., et al, 1987; Vakulenko, 
S.B. and Mobashery, S., 2003). Gram-negative aerobic bacilli are particularly sensitive to these 
antibiotics, and they are often the treatment of choice for infections from Gram-negative bacteria 
such as Escherichia coli, Salmonella spp., Shigella spp., Enterobacter spp., Citrobacter spp., 
Acinetobacter spp., Proteus spp., Klebsiella spp., Serratia spp., Morganella spp., and 
Pseudomonas spp (Vakulenko, S.B. and Mobashery, S., 2003). They are also used, generally in 
combination therapy with cell wall active agents, to treat infections caused by Gram-positive 
organisms such as Staphylococcus aureus and some streptococci (Vakulenko, S.B. and 
Mobashery, S., 2003), as well as infections due to intracellular bacteria (Maurin, M. and Raoult, 
D., 2001). 
Aminoglycosides are relatively toxic to the eukaryotic host cell. Their therapeutic 
window is rather small, which means there's a small difference between the serum concentration 
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needed for bactericidal action and the concentration of the drug that is toxic to the host (Moore, 
R.D., et al, 1987; Wright, G.D., et al, 1998). At therapeutical concentrations, aminoglycosides 
may also affect eukaryotic cells by nonspecific binding to eukaryotic ribosomes. Their use can 
cause kidney and hearing damage, since these antibiotics can concentrate in these organs 
(Bennett, W.M., et al, 1982; Brion, N., et al, 1984). In spite of the resistance problems
 
 
 
 
Figure 1.2. Chemical Structure of Gentamicin  
 
 
that have arisen since the early 1970’s and their relatively high toxicity on the host, they are still 
antibiotics of choice clinically, especially in combined therapeutic use with cell wall active β-
lactam antibiotics (Kotra, L.P., et al, 2000; Vakulenko, S.B. and Mobashery, S., 2003). 
1.2.2. Mode of Action 
Aminoglycosides act by inhibiting prokaryotic protein synthesis (Davis, B.D., 1987; 
Azucena, E. and Mobashery, S., 2001). In order to take effect, they must first reach their target, 
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the bacterial ribosome (Davis, B.D., 1987; Fourmy, D., et al, 1996). For this, they must penetrate 
the cell wall and membranes. Penetration of the antibiotic into the bacterial cell is an important 
step of their mode of action. It is an energy-dependent, rate-limiting step (Taber, H.W., et al, 
1987; Yoshizawa, S., et al, 1998). The passage of these highly polar molecules through the 
bacterial outer membrane is considered to be a self-promoted process that involves the disruption 
of lipopolisaccharide molecules by the drug, a mechanism that is presently not fully understood 
(Martin, N.L. and Beveridge, T.J., 1986; Kadurugamuwa, J.L., et al, 1993a; Kadurugamuwa, 
J.L., et al, 1993b; Yoshizawa, S., et al, 1998). Transport through the cell membrane is thought to 
depend on the electron transport machinery of the cell (Damper, P.D. and Epstein, W., 1981; 
Wright, G.D., et al, 1998; Kotra, L.P., et al, 2000) and is inhibited by divalent cations, high 
osmotic pressure, low pH and by anaerobiosis (Damper, P.D. and Epstein, W., 1981; 
Schlessinger, D., 1988; Cavallero, A., et al, 1990).   
Once inside the cell, aminoglycosides inhibit prokaryotic protein synthesis by binding to 
the 30S ribosome subunit (Pfister, P., et al, 2003; Vakulenko, S.B. and Mobashery, S., 2003). 
This binding doesn't affect the formation of the initiation complex of protein synthesis, but 
rather, it interferes with the elongation of the nascent polypeptide. The process of proofreading is 
thus compromised, resulting in misreading of the genetic code or premature termination of the 
nascent chain (Konno, T., et al, 2004). This leads to a significant number of altered proteins. 
When inserted in the cell membrane, these abnormal proteins alter the membrane permeability, 
which allows an increased entry of the antibiotic into the cell. This step, in which more and more 
of the drug is able to enter the cell and bind to the ribosomal target, leads irreversibly to cell 
death.  (Davis, B.D., 1987; Kotra, L.P., et al, 2000; Pfister, P., et al, 2003; Vakulenko, S.B. and 
Mobashery, S., 2003; Konno, T., et al, 2004). 
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1.2.3. The Ribosomal Target 
Aminoglycoside antibiotics induce misreading of the genetic code by specifically binding 
to the 16S ribosomal RNA A-site in bacteria (Fourmy, D., et al, 1996; Pfister, P., et al, 2003). In 
particular, the 2-deoxystreptamine molecule binds to the 16S rRNA, close to the A-site tRNA 
(Moazed, D. and Noller, H.F., 1987; Fourmy, D., et al, 1996). This site in the 16S rRNA to 
which aminoglycosides bind is highly conserved in bacteria, archae and eukaryotes (Moazed, D. 
and Noller, H.F., 1987; Ban, N., et al, 2000; Carter, A.P., et al, 2001). The 4,6 disubstituted 2-
deoxystreptamine aminoglycoside molecules have common chemical groups which are involved 
in making sequence–specific contacts with the particular conserved nucleotides of the 16S rRNA 
(Moazed, D. and Noller, H.F., 1987; Carter, A.P., et al, 2000).  
The specificity and nature of aminoglycoside-ribosome contacts have been determined in 
detail with A-site mutants displaying various levels of resistance and with structural studies of 
the drug-target interaction (Moazed, D. and Noller, H.F., 1987; Pfister, P., et al, 2003). In this 
regard, A-site mutants displaying resistance to aminoglycoside antibiotics have been useful to 
determine the site of action of aminoglycoside antibiotics (Pfister, P., et al, 2003). Two critical 
regions have been identified for the binding of aminoglycosides at the A-site of the ribosome; 
these are an adenine residue at position 1408 (E. coli numbering) and the positioning of the 
U1406 and U1495 bases (Pfister, P., et al, 2003). Furthermore, the effects of particular A-site 
mutations vary according to the chemical characteristics of the drug molecule. For example, an A 
to G mutation in position 1408 impairs the insertion of 6'-NH3+ aminoglycosides inside the A-
site helix, which makes these mutants display high-level resistance to these drugs (Pfister, P., et 
al, 2003). Moreover, chemical footprinting of A-site point mutants which display higher levels of 
resistance have also stressed the importance of this site in the binding and action of 
aminoglycosides (Carter, A.P., et al, 2000; Recht, M.I. and Puglisi, J.D., 2001). 
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The elucidation of the crystal structure of aminoglycoside antibiotics bound to the A-site 
of E. coli 16S ribosomal RNA has been useful in understanding the interaction of these drugs to 
their target site (Fourmy, D., et al, 1996; Carter, A.P., et al, 2000; Pfister, P., et al, 2003). 
Structural studies done with aminoglycosides such as paromomycin, tobramycin, and geneticin, 
bound to oligonucleotides which contain a minimal A-site have indicated a key role of position 
1406 of the 16S rRNA, particularly in the binding of ring III of the aminoglycoside molecule 
(Moazed, D. and Noller, H.F., 1987; Fourmy, D., et al, 1996; Fourmy, D., et al, 1998a; Fourmy, 
D., et al, 1998b; Carter, A.P., et al, 2000; Pfister, P., et al, 2003). Thus, alterations of the binding 
sites of the ribosome or the aminoglycoside molecule that reduce the binding affinity of the drug 
to the ribosome lead to varied levels of resistance, according to the nature of these changes 
(Llano-Sotelo, B., et al, 2002; Pfister, P., et al, 2003; Vakulenko, S.B. and Mobashery, S., 2003).  
1.3  Resistance to Aminoglycosides 
Organisms can be intrinsically resistant to an antimicrobial or become resistant through 
mutations or by the acquisition of new genes (Levy, S.B., 1998; Mazel, D. and Davies, J., 1999; 
Rowe-Magnus, D.A. and Mazel, D., 1999). Bacteria can acquire resistance from an outside 
source through conjugation, transformation, and transduction (Mazel, D. and Davies, J., 1999). 
These mechanisms of genetic exchange allow bacteria to obtain favorable genes from other 
bacteria (Davies, J. and Smith, D.I., 1978; Levy, S.B., 1998). Other modes of horizontal gene 
transfer such as transposition, Gram-positive conjugative transposons, and the recently described 
conjugative transposons in Gram-negative organisms, as well as the integrons of some Gram-
negative bacteria, allow bacteria to acquire new genes through intermolecular genetic exchange 
(Davies, J. and Smith, D.I., 1978; Stokes, H.W., et al, 2001; Pembroke, J.T., et al, 2002; 
Carattoli, A., 2003; Partridge, S.R. and Hall, R.M., 2003). These mobile DNA elements have 
played an important role in the evolution of microorganisms (Recchia, G.D. and Hall, R.M., 
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1997; Simjee, S. and Gill, M.J., 1997; Hall, R.M., et al, 1999; Tolmasky, M.E., 2000; Pembroke, 
J.T., et al, 2002; Rowe-Magnus, A.D., et al, 2002). 
Microorganisms can become resistant to antibiotics through a variety of mechanisms, 
which include the alteration of the drug’s target, reduced uptake or accumulation of the drug, and 
the enzymatic modification of the antibiotic (Davis, B.D., 1987; Levy, S.B., 1998; Mazel, D. and 
Davies, J., 1999).   
1.3.1. Altered Target 
There are two main modes through which bacteria can become resistant to 
aminoglycosides by modifications of the ribosome: 1) through mutations in ribosomal proteins or 
the rRNA, and 2) by enzymatic modification of the ribosome (Davis, B.D., 1987; Wright, G.D., 
et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003).  
1.3.1.1. Target-Site Mutations  
As mentioned above, any mutation that affects the binding sites of the ribosome can 
reduce the binding affinity of the drug to the ribosome and lead to varied levels of resistance. 
The effects of such mutations depend on the nature of the mutation and on the chemistry of the 
drug (Fourmy, D., et al, 1996; Carter, A.P., et al, 2000; Llano-Sotelo, B., et al, 2002). For 
example, mutations that inhibit the binding of ring I of aminoglycosides confer high-level 
resistance to these drugs (Carter, A.P., et al, 2000; Recht, M.I. and Puglisi, J.D., 2001). 
Mutations U1406-to-A confer higher levels of resistance as well as a partial dominance of 
resistance to all 4,6 disubstituted 2-deoxystrepatamine aminoglycosides, by reducing the affinity 
of the antibiotic for the rRNA target (Recht, M.I. and Puglisi, J.D., 2001; Pfister, P., et al, 2003). 
Mutational changes in the 16S rRNA, or on ribosomal proteins, have been reported to 
produce resistance mainly to streptomycin (Fernandez, R.O. and Anton, D.N., 1987; Melancon, 
P., et al, 1988). These mutations are of clinical importance, particularly in Mycobacterium 
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tuberculosis, since streptomycin is one of the drugs used for the treatment of tuberculosis 
(Gillespie, S.H., 2002; Vakulenko, S.B. and Mobashery, S., 2003).  
1.3.1.2. Enzymatic Modification of the Target Site  
The other mode of target site alteration leading to aminoglycoside resistance is through 
the enzymatic modification of the ribosome (Davis, B.D., 1987; Cundliffe, E., 1989; Wright, 
G.D., et al, 1998). It is not uncommon to find modifications of the ribosome in microorganisms 
producing antibiotics that target the ribosome, as a way of protecting themselves from the 
antibiotics they produce (Cundliffe, E., 1989; Yoshizawa, S., et al, 1998). An example of this 
can be found in some aminoglycoside-producing microorganisms where methylation of certain 
guanine residues of the 16S rRNA produce high-level resistance to aminoglycoside antibiotics 
(Cundliffe, E., 1989; Vakulenko, S.B. and Mobashery, S., 2003). Ribosomal modification has 
been well documented in the gentamicin producer Micromonospora purpurea, as well as other 
aminoglycoside-producers, such as Streptomyces tenjimariensis and Streptomyces tenebrarius 
(Piendl, W. and Bock, A., 1982; Piendl, W., et al, 1984; Cundliffe, E., 1989). 
For years, several studies strived to identify the genes that confer high-levels of resistance 
in organisms that produce aminoglycosides (Cundliffe, E., 1989; Kojic, M., et al, 1992). Some of 
this research has focused on methylase enzymes which confer aminoglycoside resistance to 
aminoglycoside producing organisms (Thompson, J., et al, 1985). In one of these studies, J. 
Thompson et al (1985) cloned fragments from the gentamicin producer, Micromonospora 
purpurea into naïve E. coli cells and obtained a strain which was highly resistant to both 
gentamicin and to kanamycin. The cloned methylase activity acted on the 16S RNA 30S 
ribosomal subunits of E. coli, to produce the mentioned resistance phenotype. Later, in 1987, A. 
A. Beauclerk and E. Cundliffe observed the sites of action of Micromonospora purpurea’s rRNA 
methylases and determined that these enzymes made this aminoglycoside-producer resistant to 
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high levels of gentamicin by the conversion of residue G-1405 to 7-methylguanosine within the 
bacterial 16S ribosomal RNA (Beauclerk, A.A. and Cundliffe, E., 1987). The nature of such 
interactions has also been studied in detail, based on sequence analysis as well as structural 
studies (Carter, A.P., et al, 2000; Bujnicki, J.M. and Rychlewski, L., 2002).  
Another group of researchers studied the aminoglycoside-resistance determinants that 
they cloned from Micromonospora purpurea and the sisomicin producer Micromonospora rosea 
(Kelemen, G.H., et al, 1991). They found that these resistance determinants showed a high 
degree of identity between them, both at the structural and the functional level. Their studies 
allowed them to identify the grm gene, which encodes a ribosomal RNA methyltransferase. 
Furthermore, M. Kojic and collaborators (Kojic, M., et al, 1992) cloned a sisomicin-gentamicin 
resistance methylase gene (sgm) from Micromonospora zionensis and found that its deduced 
amino acid sequence also showed similarity to Grm enzymes, as well as to the 16S rRNA 
methylase, KgmB.  
The studies mentioned above show the effects that methylation of the ribosome can have 
on aminoglycoside efficiency. The importance of the background of the aminoglycoside 
producer strain for the effective action of gentamicin-resistance determinants has also been 
investigated (Kojic, M., et al, 1999). Consequently, Micromonospora spp. strains that produce 
aminoglycosides have been shown to express high-levels of resistance to their own products as 
well as to antibiotics that are structurally similar, that is, those with a 4,6-disubstituted 
deoxystreptamine aminocyclitol component (neomycin, kanamycin, or gentamicin). On the other 
hand, these strains also proved to be sensitive to aminoglycoside antibiotics in which the 
aminocyclitol ring had different types of substitutions, such as neomycin and apramycin (Kojic, 
M., et al, 1999). These studies, which illustrate the importance of the aminoglycoside producer 
background for the action of a particular resistance determinant, provide clues to the impact on 
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the phenotype that ribosomal modification for self-protection has in antibiotic producers (Kojic, 
M., et al, 1999).  
Aminoglycoside resistance by enzymatic modification of the ribosome has recently 
become an important focus of study due to the discovery of enzymes that modify the 16SrRNA 
in bacteria other than antibiotic producers (Galimand, M., et al, 2003; Yokoyama, K., et al, 
2003; Doi, Y., et al, 2004; Yamane, K., et al, 2004). This mode of aminoglycoside resistance by 
modifications of the target involving enzymatic methylation of the rRNA in non-antibiotic 
producers will be explained in a later section. 
1.3.2. Adaptive Resistance 
Adaptive resistance to aminoglycosides, which is a transient, reduced susceptibility to the 
drug, has been reported mainly in aerobic Gram-negative bacilli (Davis, B.D., 1987; Wright, 
G.D., et al, 1998). An example of these studies is one performed by Karlowski et al,1996, where 
these researchers observed that stepwise increases in aminoglycoside concentrations allowed 
Pseudomonas aeruginosa to grow in concentrations of aminoglycosides that would normally kill 
the parent strains. However, adaptive changes are typically unstable, and are due to regulatory 
events rather than mutations or the acquisition of resistance genes, so they don’t persist once the 
selective pressure is removed (Karlowsky, J.A., et al, 1996). It is argued that such reduced 
susceptibility could be due to protein changes or alteration in regulation genes of the respiratory 
pathway, but the actual mechanism is poorly understood (Bryan, L.E. and Van Den Elzen, H.M., 
1977; Karlowsky, J.A., et al, 1996). 
1.3.3. Drug Impermeability: Reduced Uptake and Active Efflux of Antibiotics 
In order to take effect, aminoglycosides must first penetrate the cell wall and membranes, 
and reach the bacterial ribosome (Bryan, L.E. and Van Den Elzen, H.M., 1977; Martin, N.L. and 
Beveridge, T.J., 1986; Davis, B.D., 1987). Some microorganisms have developed ways to inhibit 
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this important step of these drugs’ mode of action. Aminoglycoside resistance due to reduced 
uptake of the drug is mainly seen in the pseudomonads and other non-fermentor Gram-negative 
bacilli (Bryan, L.E. and Van Den Elzen, H.M., 1977; Martin, N.L. and Beveridge, T.J., 1986). 
The mechanism of action of reduced drug uptake is generally due to membrane 
impermeabilization, which impairs the drug penetration into the cell (Bryan, L.E. and Van Den 
Elzen, H.M., 1977; Davis, B.D., 1987). This mode of resistance is clinically important since it is 
stable and it results in an intermediate susceptibility to all of the aminoglycosides (Miller, G.H., 
et al, 1997; Lister, P.D., 2002). The precise molecular mechanisms that produce the 
aminoglycoside impermeability type of resistance are yet unknown (Damper, P.D. and Epstein, 
W., 1981; Davis, B.D., 1987; Schlessinger, D., 1988).   
Another mechanism bacteria use to reduce the accumulation of an antibiotic within the 
cell is through the active efflux, or pumping, of the drug out of the cell (Zgurskaya, H.I. and 
Nikaido, H., 2000). This mechanism is more frequently observed in non-fermentor Gram-
negative bacilli (Martin, N.L. and Beveridge, T.J., 1986; Westbrock-Wadman, S., et al, 1999), 
but has been reported in other microorganims as well, including Samonella spp. and E. coli 
(Nikaido, H., et al, 1998; Rosenberg, E.Y., et al, 2000). Multidrug efflux pumps generally have 
low substrate specificity (Zgurskaya, H.I. and Nikaido, H., 2000). Furthermore, the presence of 
different efflux pumps may confer additive or multiplicative effects on drug resistance (Lee, A., 
et al, 2000). Multidrug efflux pumps confer Gram-negative bacteria useful survival strategies, 
which can follow the acquisition of foreign genes, as well as the activation or increased 
expression of innate efflux systems (Westbrock-Wadman, S., et al, 1999; Putman, M., et al, 
2000; Zgurskaya, H.I. and Nikaido, H., 2000; Lister, P.D., 2002).   
Efflux pump systems have been classified in different families. ATP-dependent 
multidrug transporters are those which use ATP as the energy source to drive the drug outside of 
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the cell.  Secondary multidrug transporters mediate the efflux of antibiotics from the cell in a 
combined exchange with protons. The latter include 1) the major facilitator superfamily, 2) the 
small multidrug resistance superfamily, 3) the multidrug and toxic compound extrusion 
superfamily and 4) the resistance-nodulation-cell division family (Nikaido, H., et al, 1998; 
Zgurskaya, H.I. and Nikaido, H., 2000; Mao, W., et al, 2001; Lister, P.D., 2002).   
Pseudomonas aeruginosa, which is an important nosocomial pathogen that often presents 
difficulties in therapy, is a non-fermentor Gram-negative bacillus which possesses intrinsic 
resistance to multiple drugs (Lister, P.D., 2002). Over 90% of aminoglycoside-resistant P. 
aeruginosa isolates from cystic fibrosis patients display the drug impermeability phenotype 
(Westbrock-Wadman, S., et al, 1999; Lister, P.D., 2002), highlighting the importance of this 
mechanism of resistance. P. aeruginosa’s natural resistance to aminoglycosides involves an 
active efflux system, or pumps, as shown by aminoglycoside accumulation assays in mutants. 
These involve energy-dependent systems that pump out aminoglycosides from the cell (Aires, 
J.R., et al, 1999). Some examples of efflux pumps which confer resistance to aminoglycosides 
include the MexXY-OprM efflux pump system found in P. aeruginosa (Mao, W., et al, 2001) 
and the AcrD pump reported in E. coli (Rosenberg, E.Y., et al, 2000). 
1.3.4. Enzymatic Modification of the Drug   
The most important mechanism of aminoglycoside resistance is the enzymatic 
modification of the antibiotic by Aminoglycoside Modifying Enzymes (AMEs), which results in 
a molecule with decreased binding affinity to the target site at the ribosome (Wright, G.D., et al, 
1998; Vakulenko, S.B. and Mobashery, S., 2003). This mode of resistance involves the presence 
of genes that code for enzymes that modify these antibiotics. The family of AMEs is divided in 
three main classes according to their enzymatic activity: 1) the aminoglycoside 
phosphoryltransferases (APH) participate in the ATP-dependent phosphorylation of hydroxyl 
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groups in the drug; 2) the aminoglycoside nucleotidyltransferases (ANT) catalyze the ATP-
dependent adenylation of certain hydroxyl groups; and 3) the aminoglycoside acetyltransferases 
(AAC) participate in the acetylCoA-depedent acetylation of specific aminoglycoside amino 
groups (Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Azucena, E. and Mobashery, S., 2001; 
Vakulenko, S.B. and Mobashery, S., 2003). This last class of the AMEs constitutes the largest 
group in the family and is the group relevant to this study (Shaw, K.J., et al, 1993; van de 
Klundert, J.A. and Vliegenthart, J.S., 1993). 
1.3.4.1. Nomenclature of Aminoglycoside Modifying Enzymes 
AMEs display substrate specificity, which means that each enzyme will modify a specific 
chemical group, resulting in a particular phenotype (Shaw, K.J., et al, 1993; Wright, G.D., et al, 
1998). Due to the large number of AMEs that have been described to date, a uniform 
nomenclature system was proposed by K.J. Shaw (Shaw, K.J., et al, 1993) to denominate these 
enzymes and avoid confusion. Briefly, the first three letters of the name should refer to the 
enzymatic action, followed by a number in parenthesis designating the group modified, then a 
Roman numeral, indicating the resistance profile, and lastly, a lower case letter indicating the 
individual gene or enzyme (Shaw, K.J., et al, 1993; van de Klundert, J.A. and Vliegenthart, J.S., 
1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Figure 1.3, Figure 
1.4 and Figure 1.5 indicate the chemical groups of an aminoglycoside molecule modified by 
different AMEs. 
1.3.4.2. Aminoglycoside Acetyltransferases 
Aminoglycoside acetyltransferases are the largest group in the family of the AMEs 
(Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998). There are four classes of enzymes within this 
group, according to the amino group that is acetylated in the aminoglycoside molecule. These are 
AAC(1), AAC(3), AAC(2”), and AAC(6”) (Shaw, K.J., et al, 1993). These enzymes use the 
 17
acetyl group from an acetyl coenzyme-A donor molecule to modify the aminoglycoside molecule 
at the 1 and 3 positions of the 2-deoxystreptamine ring, and the 2” and 6” positions of the 6-
aminohexose ring, respectively (Shaw, K.J., et al, 1993; Vakulenko, S.B. and Mobashery, S., 
2003).   
Several resistance patterns have been found within the class of AACs which modify the 
aminoglycoside molecule at position 3 of the 2-deoxystreptamine ring, or AAC(3). One of the 
resistance phenotypes of interest in this study corresponds to the AAC(3)-II resistance pattern 
(Diaz, M.A., et al, 2000; Diaz, M.A., et al, 2001). The phenotype of these enzymes involves 
resistance to gentamicin, tobramycin, sisomicin, netilmicin, and dibekacin (Shaw, K.J., et al, 
1993; Miller, G.H., et al, 1997; Vakulenko, S.B. and Mobashery, S., 2003). Three different 
aac(3)-II genes have been identified to date, which encode enzymes AAC(3)-IIa, -IIb, and -IIc. 
Genes aac(3)-IIc and aac(3)-IIb have been reported to share 97% and 72% identity with the 
aac(3)-IIa gene, respectively (Vakulenko, S.B. and Mobashery, S., 2003). These enzymes had 
previously been named AAC(3)-III (Allmansberger, R., et al, 1985) and AAC(3)-V (Brau, B., et 
al, 1984; Rather, P.N., et al, 1992) until later analysis revealed them to be identical to the 
AAC(3)-II (Shaw, K.J., et al, 1993; Vakulenko, S.B. and Mobashery, S., 2003).  
Clinically, AAC(3)-II enzymes are frequently found in Gram-negative bacteria, with a 
frequency that varies from 18% to 60% relative to other phenotypes (Miller, G.H., et al, 1997; 
Vakulenko, S.B. and Mobashery, S., 2003). The most frequent gene producing the AAC(3)-II 
phenotype is AAC(3)-IIa, which accounts for 85% of the bacteria presenting this phenotype 
(Miller, G.H., et al, 1997). This gene was originally identified in R-plasmids (Allmansberger, R., 
et al, 1985).  
Three other AAC(3) resistance patterns, AAC(3)-III, AAC(3)-IV, and AAC(3)-VI, occur 
rarely among clinical isolates, and patterns AAC(3)-VII, -VIII, -IX, and -X have been discovered  
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in aminoglycoside- producing actinomycetes (Vakulenko, S.B. and Mobashery, S., 2003). The 
phenotype of AAC(3)-VI, of interest in this investigation, includes resistance to gentamicin 
(Shaw, K.J., et al, 1993; Miller, G.H., et al, 1997; Diaz, M.A., et al, 2000; Diaz, M.A., et al, 
2001; Vakulenko, S.B. and Mobashery, S., 2003). The gene aac(3)VI was originally cloned from 
a conjugative plasmid of Enterobacter cloacae. It reportedly shares 50% amino acid identity 
with the deduced amino acid sequence from the aac(3)-IIa gene (Rather, P.N., et al, 1993; 
Vakulenko, S.B. and Mobashery, S., 2003).   
1.4  High-Level Gentamicin Resistance (HLGR) 
1.4.1. HLGR in Gram-Positive Organisms 
The majority of aminoglycoside modifying enzymes present enough activities to result in 
effective resistance to aminoglycosides, but only certain phosphotransferase enzymes have been 
reported to produce high-levels of resistance to these antibiotics (Galimand, M., et al, 2003; 
Vakulenko, S.B. and Mobashery, S., 2003). To the best of our knowledge, there had been no 
reports in the literature of high-level resistance to gentamicin in Gram-negative bacteria before 
the start of this study in 1999 (Diaz, M.A., et al, 2000). There had been numerous reports on 
high-level gentamicin resistance in Gram-positive bacteria (Chow, J.W., 2000). Reports on the 
variety of structures involved in the transfer of these determinants in Gram-positive bacteria 
were also abundant (Ferretti, J.J., et al, 1986; Chow, J.W., 2000).  
The enzyme AAC(6’)-APH(2”) was the first to be reported to cause the high-level 
gentamicin resistance phenotype (Shaw, K.J., et al, 1993; Chow, J.W., 2000). It confers high-
level gentamicin resistance to Gram-positive organisms due to its 6'-N-acetyltransferase and 2"-
O-phosphotransferase activities (Shaw, K.J., et al, 1993). The combined acetylation and 
phosphorylation of specific amino and hydroxyl groups by this enzyme gives it a broad substrate 
specificity in both enzymatic activities (Wright, G.D., et al, 1998; Kotra, L.P., et al, 2000). This 
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enzyme makes aminoglycoside therapy inefficient for the treatment of pathogenic enterococci 
and staphylococci (Daigle, D.M., et al, 1999; Chow, J.W., 2000).   
High-level aminoglycoside resistance in enterococci is generally mediated by these 
aminoglycoside-modifying enzymes (Fluit, A.C., et al, 2003). This level of resistance eliminates 
the synergistic bactericidal effect that is normally obtained by the combined use of cell wall-
active agents, such as β-lactams, with aminoglycosides (Chow, J.W., 2000), which is clinically 
relevant since this is often a treatment of choice for infections caused by these microorganisms 
(Miller, G.H., et al, 1997; Vakulenko, S.B. and Mobashery, S., 2003).   
High-level gentamicin resistance, often refered to as HLGR, is found in almost all 
enterococcal species involved in human infection (Straut, M., et al, 1996; Chow, J.W., 2000; 
Fluit, A.C., et al, 2003). In fact, the majority of Enterococcus spp. tested to date have been 
shown to encode genes with homology to the gene aac(6’)-aph(2”), also found in the literature 
as the aac6-aph2 gene (Ferretti, J.J., et al, 1986).  
The gene coding this bifunctional enzyme has been reported to be carried either by 
Tn4001-like structures or by Tn4001-truncated elements (Ferretti, J.J., et al, 1986) and to present 
insertion sequences IS256 and IS257 in its molecular environment. It has been detected in other 
HLGR strains of Gram-positive bacteria, such as Staphylococcus aureus, Streptococcus spp., 
Ent. faecalis and Ent. faecium (Ferretti, J.J., et al, 1986), and in the chromosome of 
Streptococcus mitis (Kaufhold, A. and Potgieter, E., 1993). Plasmid-borne gene aac(6’)-aph(2”) 
has also been detected in other enterococcal species displaying HLGR, namely Ent. hirae, Ent. 
avium, and Ent. raffinosus (Sahm, D.F. and Gilmore, M.S., 1994; Straut, M., et al, 1996; 
Shiojima, M., et al, 1997). The genes encoding this bifunctional enzyme have been shown to be 
highly homologous in Enterococcus faecalis, Enterococcus faecium, and Streptococcus 
agalactiae (Ounissi, H., et al, 1990; Kaufhold, A., et al, 1992).   
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Recently, other genes have been reported to account for plasmid-encoded high-level 
gentamicin resistance in Enterococcus faecium (Chow, J.W., 2000; Vakulenko, S.B. and 
Mobashery, S., 2003). In 1998, S.F. Tsai et al identified a new high-level gentamicin resistance 
gene, aph(2'')-Id, in Enterococcus spp. (Tsai, S.F., et al, 1998). The deduced amino acid 
sequence for this gene has a region which presents homology to the aminoglycoside-modifying 
enzyme APH(2'')-Ic, which reportedly confers mid-levels resistance to gentamicin (Chow, J.W., 
et al, 1997); it also presents homology to the C-terminal domain of the bifunctional enzyme 
AAC(6')-APH(2'') (Chow, J.W., et al, 1997; Chow, J.W., et al, 2001; Vakulenko, S.B. and 
Mobashery, S., 2003). Later, in 2000, S.J. Kao et al cloned a new high-level gentamicin 
resistance gene, aph(2")-Ib, from Enterococcus faecium strain SF11770, with homology to the 
enzymes AAC(6’)-APH(2”), APH(2")-Ic, and APH(2")-Id (Kao, S.J., et al, 2000). Interestingly, 
gene aph(2”)-Ib was recently detected in E. coli as well as in Enterococcus faecium, findings 
that suggest a horizontal transfer of these genes between Gram-positive and Gram-negative 
bacteria (Chow, J.W., et al, 2001). In conclusion, recently reported genes accounting for 
plasmid-encoded high-level gentamicin resistance in Enterococcus faecium include: aph(2”)-Ib 
and aph(2”)-Id (Tsai, S.F., et al, 1998; Chow, J.W., 2000; Kao, S.J., et al, 2000). It is relevant to 
mention that even though aph(2”)-Ib has been reported in Gram-negative bacteria, there are no 
reports to date of any aminoglycoside modifying enzyme causing the HLGR phenotype in these 
bacteria (Galimand, M., et al, 2003; Yamane, K., et al, 2005). 
1.4.2. Transfer of Gentamicin Resistance Genes in Gram-Positive Organisms 
Various reports in Europe, the United States, and other places in the world have 
ascertained that HLGR is an important cause of nosocomial enterococcal infections (Murray, 
B.E., 1990; Fluit, A.C., et al, 2003). This may in part be due to the fact that HLGR determinants 
are present on mobile molecular elements which can facilitate their spread among Gram-positive 
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organisms (Ferretti, J.J., et al, 1986; Tolmasky, M.E., 2000; Fluit, A.C., et al, 2003). In this 
sense, several reports have revealed an ample variety of structures associated with the genetic 
variability and transfer of gentamicin resistance in Gram-positive organisms. For example, some 
studies have described the plasmid contents in clinical isolates of HLGR Enterococcus faecalis 
as highly heterogenous (Zervos, M.J., et al, 1986; Casetta, A., et al, 1998; Daikos, G.L., et al, 
2003). These have found the gentamicin resistance determinants either on conjugative, or on 
nonconjugative, mobilizable plasmids. In addition, the bi-functional enzyme AAC(6’)-APH(2”) 
has been found to be encoded on both narrow and broad host range plasmids (Simjee, S. and 
Gill, M.J., 1997), as well as on conjugative transposons (Sahm, D.F. and Gilmore, M.S., 1994; 
Casetta, A., et al, 1998; Murray, B.E., 1998; Culebras, E. and Martinez, J.L., 1999; Simjee, S., et 
al, 1999).  
Overall, studies on gentamicin resistance in enterococci report isolating plasmids from 
transconjugants with sizes ranging from 45 kb to larger than 80 kb. All these plasmids are 
reported to carry the gene aac(6’)-aph(2”) for HLGR. Nevertheless, the molecular environment 
or flanking regions of this gene is reported to vary significantly (Sahm, D.F. and Gilmore, M.S., 
1994; Horvat, R.T., et al, 1998; Simjee, S., et al, 1999). As an example of this variability, one 
study reported this gene to be found as a Tn4001-like alpha element on the Ent. faecalis 
chromosome, as well as a Tn4001-truncated type I structure on a conjugative plasmid, and even 
on both (Casetta, A., et al, 1998). The heterogeneity observed in plasmid contents and in the 
molecular environments of this gene in clonally related enterococci argues against a clonal 
dissemination of gentamicin resistant strains (Culebras, E. and Martinez, J.L., 1999).  
Studies done on Ent. faecalis have further characterized the plasmids carrying the HLGR 
determinants as pheromone-responsive conjugative plasmids (Shiojima, M., et al, 1997; Murray, 
B.E., 1998). These pheromone-responsive plasmids are characterized by giving a mating 
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response to small sex pheromones secreted by potential recipient cells. This event is involved in 
the formation of mating aggregates and plasmid transfer (Salyers, A.A., et al, 1995; Shiojima, 
M., et al, 1997; Tolmasky, M.E., 2000). Until recently, conjugative transposons had only been 
reported in Gram-positive bacteria (Salyers, A.A., et al, 1995). However, recent studies 
(Pembroke, J.T., et al, 2002) have described the presence of similar though unrelated structures 
in Gram-negative bacteria. This subject has become a hot topic since and will be discussed in a 
later section. 
HLGR genes can also be transferred among different genera of Gram-positive organisms 
(Sahm, D.F. and Gilmore, M.S., 1994). One example of this is a study which identifies the same 
antimicrobial resistance genes in enterococci and staphylococci on the enterococcal transposon 
Tn5384. The study supports the evolution of a composite transposon through cointegration of 
enterococcal and staphylococcal plasmids, though this genetic transfer between enterococci and 
staphylococci is still not well defined nor understood. Additionally, the molecular structures 
mentioned so far also play a key role in the dissemination of resistant strains between different 
regions of the world (Fluit, A.C., et al, 2003; Hallgren, A., et al, 2003). This dissemination is 
illustrated by a study in the UK (Simjee, S., et al, 1999) that detected a Tn5281-like element 
carrying the aac(6’)-aph(2”) gene (with and without an associated 70 kb plasmid) in clinical 
isolates of Enterococcus faecium, which had been originally detected in a Enterococcus faecalis 
strain HH22 from the USA (Daigle, D.M., et al, 1999; Simjee, S., et al, 1999).   
In general, studies conducted on the origin and spread of the aac(6’)-aph(2”) gene 
suggest that the origin of this gene is not clonal, but it is rather due to the combination of events 
such as plasmid conjugation, together with multiple insertion events, which have facilitated the 
rapid spread of this aminoglycoside resistance gene among Gram-positive bacteria (Simjee, S. 
and Gill, M.J., 1997; Culebras, E. and Martinez, J.L., 1999).  
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1.5  Integrons 
1.5.1. Definition and Classes 
Integrons are gene-capture molecular elements that contain an integrase gene, named intI, 
and an arrangement of gene cassettes which are expressed from a common promoter (Stokes, 
H.W. and Hall, R.M., 1989; Collis, C.M. and Hall, R.M., 1995). They were first described by 
H.W. Stokes and R.M. Hall (Stokes, H.W. and Hall, R.M., 1989) and since then, the literature 
abounds with reports of these molecular elements, which are often found on the plasmids and/or 
the chromosomes of Gram-negative bacteria (Hall, R.M. and Stokes, H.W., 1993; Recchia, G.D. 
and Hall, R.M., 1997; Fluit, A.C. and Schmitz, F.J., 1999; Hall, R.M., et al, 1999; Rowe-
Magnus, D.A. and Mazel, D., 1999).  
Gene cassettes are defined as small mobile elements generally composed of a single gene, 
plus a site known as the 59-base element (59be) or attC (Stokes, H.W. and Hall, R.M., 1989; 
Hall, R.M. and Collis, C.M., 1995). Gene cassettes can be inserted or excised from the integron 
through site-specific recombination, an event that is catalized by the integrase IntI (Stokes, H.W. 
and Hall, R.M., 1989; Collis, C.M. and Hall, R.M., 1992b; Hall, R.M. and Collis, C.M., 1995; 
Stokes, H.W., et al, 1997; Collis, C.M., et al, 2001).  
The majority of gene cassettes described to date code for antibiotic resistance (Fluit, A.C. 
and Schmitz, F.J., 1999; Fluit, A.C. and Schmitz, F.J., 2004). Integrons which encode these 
resistance genes are known as Multiple Resistance Integrons or MRIs. More than 70 different 
antibiotic resistance gene cassettes have been reported in the MRIs to date, and they include 
resistance genes to most of the existing antibiotic families (Recchia, G.D. and Hall, R.M., 1995; 
Fluit, A.C. and Schmitz, F.J., 1999; Mazel, D. and Davies, J., 1999).  
Integrons are divided into different classes, according to the IntI integrase and the general 
gene arrangement that they encode. Before 2001, only four classes of integrons had been 
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identified, mainly from clinical isolates. These were integrons class-1 (Stokes, H.W. and Hall, 
R.M., 1989), class-2, class-3 (Collis, C.M., et al, 2002a) and class-4 (Mazel, D., et al, 1998).  
Class-4 integrons are what is now called the Vibrio cholerae Super Integron (Mazel, D., 
et al, 1998; Clark, C.A., et al, 2000). This larger type of integron, referred to as “super-
integrons” or SIs and originally described in Vibrio cholerae (Mazel, D., et al, 1998; Rowe-
Magnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D., 1999; Clark, C.A., et al, 2000), 
were later found as integral components of the genomes of other γ-proteobacteria, such as 
Xanthomonas spp., Shewanella spp. and Pseudomonas spp. (Rowe-Magnus, D.A., et al, 1999; 
Rowe-Magnus, D.A. and Mazel, D., 1999; Vaisvila, R., et al, 2001).  
SIs are believed to have played an important role in bacterial gene exchange and 
evolution (Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D., 2001; Rowe-
Magnus, D.A., et al, 2002; Fluit, A.C. and Schmitz, F.J., 2004). Their gene cassettes can be 
implicated in virulence or other functions different from drug resistance, as recently observed in 
cassette-encoded genes with metabolic functions in the class-4 integron on the Vibrio cholerae 
genome (Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D., 2001; Rowe-
Magnus, D.A., et al, 2003). This finding advocates for a broader role for these bacterial elements 
in adaptive bacterial evolution than originally considered (Rowe-Magnus, D.A., et al, 2001; 
Rowe-Magnus, D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz, F.J., 2004). 
In addition to the four classes of integrons originally reported (Stokes, H.W. and Hall, 
R.M., 1989; Mazel, D., et al, 1998; Collis, C.M., et al, 2002a), new integron classes have been 
discovered in recent studies (Nield, B.S., et al, 2001; Stokes, H.W., et al, 2001). This Australian 
group designed degenerate primers from conserved sequences in the genes coding for the known 
integrases and used them to screen for new putative integrases in environmental samples. This 
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same screening strategy proved helpful in a later study conducted to detect new gene cassettes 
from the environment (Stokes, H.W., et al, 2001).  
1.5.2. Class-1 Integrons: Structure 
Class-1 integrons are the most prevalent integrons among clinical isolates (Hall, R.M. 
and Stokes, H.W., 1993; Fluit, A.C. and Schmitz, F.J., 1999). They are characterized by the 
presence of two conserved sequences, known as the 5’CS and 3’CS, which flank a variable 
region (Figure 1.6) (Bennett, P.M., 1999). The 5'-conserved region contains the integrase gene 
intI1 and a gene cassette attachment site, attI. The 3'-conserved region is characterized by the 
presence of a sulfonamide resistance gene, sul1, a quaternary ammonium compound resistance 
gene, qacE∆1, and open reading frames orf5 and orf6, with unknown functions. The variable 
region of class-1 integrons can code for one or more gene cassettes (Stokes, H.W. and Hall, 
R.M., 1989; Hall, R.M. and Stokes, H.W., 1993).  
Gene cassettes are excised from integrons as covalently-closed circles (Collis, C.M. and 
Hall, R.M., 1992b; Collis, C.M. and Hall, R.M., 1992a). They are generally inserted at a specific 
site in the integron, known as the attI site (Collis, C.M. and Hall, R.M., 1992b; Collis, C.M., et 
al, 1993; Stokes, H.W., et al, 1997). This site, together with the 59be site, are the substrates for 
the site-specific recombinase IntI (Hall, R.M. and Collis, C.M., 1995; Collis, C.M., et al, 1998; 
Collis, C.M., et al, 2001). The majority of gene cassettes are found integrated at the attI site of 
integrons, but some gene cassettes have also been described on secondary sites, or 2°rs (Stokes, 
H.W. and Hall, R.M., 1989; Recchia, G.D., et al, 1994; Hall, R.M. and Collis, C.M., 1995; 
Recchia, G.D. and Hall, R.M., 1995; Collis, C.M., et al, 2001). IntI integrases bind preferentially 
to the adjacent attI site for the recombination reaction with a 59be site (Collis, C.M., et al, 
2002b). 
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As mentioned above, gene cassettes possess a 59be which, together with the attI site, 
serves as the substrate for the integron integrase (Collis, C.M., et al, 1993; Hall, R.M. and Collis, 
C.M., 1995; Stokes, H.W., et al, 1997). The 59be or attC sites of different gene cassettes can 
vary considerably in their length and in sequence. Thus, they can measure anywhere from 57 to 
141 base pairs (Hall, R.M., et al, 1991; Collis, C.M., et al, 1993; Hall, R.M. and Collis, C.M., 
1995).  
 
 
 
 
Figure 1.6. General Structure of a Class-1 Integron 
 
 
 
59-base elements are unique for each gene cassette. There are regions at the ends of these 
sites, measuring approximately 25 bp, which display a certain degree of similarity and which are 
imperfect inverted repeats of each other (Hall, R.M., et al, 1991; Collis, C.M., et al, 1993; Hall, 
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R.M. and Collis, C.M., 1995). Each of these sequences contain inversely oriented integrase-
binding domains, which have the consensus sequences, RYYYAAC and G↓TTRRRY (Hall, 
R.M., et al, 1991; Collis, C.M., et al, 1993; Hall, R.M. and Collis, C.M., 1995; Rowe-Magnus, 
D.A., et al, 2001). They are known as the inverse core site (ICS) and the core site (CS) of gene 
cassettes, respectively. They are separated by a spacer of 7 or 8 bp (Hall, R.M., et al, 1991; 
Stokes, H.W., et al, 1997). 
As opposed to attC sites, integron attI sites are not closely related to each other, and they 
do not share the features described in the previous paragraphs for attC (Hall, R.M., et al, 1991; 
Partridge, S.R., et al, 2000). The attI site only has one site structure, with two directly repeated 
integrase-binding domains located at the left side (Collis, C.M. and Hall, R.M., 1995; Hall, R.M. 
and Collis, C.M., 1995; Collis, C.M., et al, 2001).  
As mentioned above, the sequences which flank gene cassettes can vary a great deal 
between the different integron classes (Hall, R.M., et al, 1994; Stokes, H.W., et al, 1997; Stokes, 
H.W., et al, 2001). However, identical cassettes have been found to be encoded in integrons of 
different classes, which indicates that the gene cassette pool is probably shared between them 
(Fluit, A.C. and Schmitz, F.J., 1999; Rowe-Magnus, D.A. and Mazel, D., 1999; Rowe-Magnus, 
D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz, F.J., 2004). The fact that gene cassettes may 
possibly be exchanged between the different integron classes advocates that they may have 
played an important role in bacterial evolution (Rowe-Magnus, D.A. and Mazel, D., 1999; 
Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D., 2001; Rowe-Magnus, 
D.A., et al, 2002). In effect, the flexibility that integrons confer to bacteria allows them to adapt 
rapidly to unpredictable environmental challenges by allowing bacteria to acquire favorable 
genes that can result in an improved fitness (Hall, R.M., et al, 1999; Rowe-Magnus, D.A. and 
Mazel, D., 1999; Rowe-Magnus, D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz, F.J., 2004). 
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Likewise, any gene that proves to be useless may be eliminated via a similar mechanism (Hall, 
R.M., et al, 1999; Fluit, A.C. and Schmitz, F.J., 2004). On the other hand, the majority of the 
cassettes in the SIs are not expressed. Even so, they are believed to be maintained in the absence 
of selective pressure as a genetic resource for the evolution of new genes (Rowe-Magnus, D.A. 
and Mazel, D., 1999; Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D., 
2001; Rowe-Magnus, D.A., et al, 2002).   
The origins of the gene cassettes are not known, yet it is suggested that cassettes from 
multiple resistance integrons may be relatively ancient structures (Recchia, G.D. and Hall, R.M., 
1997). Moreover, it is suspected that MRIs evolved from super integrons through the recruitment 
of super-integron gene cassettes (Rowe-Magnus, D.A., et al, 2002; Hall, R.M. and Stokes, H.W., 
2004). This is illustrative of how super-integrons have had an important impact on the bacterial 
evolution of antibiotic resistance through the recruitment of super-integron gene cassettes 
(Rowe-Magnus, D.A., et al, 2002; Hall, R.M. and Stokes, H.W., 2004).  
1.5.3. Gene Expression 
Integrons can be regarded as natural bacterial expression vectors (Collis, C.M. and Hall, 
R.M., 1995; Hall, R.M. and Collis, C.M., 1995). There is a considerable degree of variability in 
the level of expression of the genes encoded as gene cassettes. This variability of expression can 
be accounted for by the intrinsic characteristics of both the gene cassettes and the integron 
(Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995; Hall, R.M. and Collis, C.M., 1995; 
Recchia, G.D. and Hall, R.M., 1995).   
The expression of gene cassettes has been intensely studied at the transcriptional level 
(Collis, C.M. and Hall, R.M., 1995; Hall, R.M. and Collis, C.M., 1995; Ploy, M.C., et al, 2000). 
Gene cassettes are inserted in integrons in the same orientation with respect to their coding 
sequence. Their initiation codons are located close to their 5’ end (Hall, R.M. and Collis, C.M., 
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1995). With a few exceptions, gene cassettes do not contain a promoter of their own. They are 
instead expressed from a common promoter, Pant or P1, or rarely from another promoter, P2 
(Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995; Stokes, H.W., et al, 2001). The P1 
promoter sequence has strong sequence similarity to the Escherichia coli σ70 promoter consensus 
sequence. Both P1 and P2 promoters are located in the 5’-conserved segment (5’-CS) of class 1 
integrons. Pant is in a region in the 5’-CS called the 59-conserved segment, located at 59 bases 
from the gene cassettes; it is 200 bp upstream from the cassette-encoded genes inserted at the 
attI1 site (Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995).   
Several factors can affect the expression of the gene cassettes in an integron (Ploy, M.C., 
et al, 2000). Multiple studies on the promoter sequences have confirmed that variations in the 
sequence of Pant can affect the level of expression of a given gene by more than 20-fold 
(Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995). Thus, mutations and natural 
variants of Pant have been shown to have an effect on the expression of gene cassettes, as 
measured by the level of antibiotic resistance conferred by the cassettes encoded downstream of 
such promoters (Levesque, C., et al, 1994; Ploy, M.C., et al, 2000). Another factor that can 
significantly affect the expression of gene cassettes is the order in which the cassette is inserted 
in the integron. Thus, the level of resistance conferred is higher for the resistance genes that are 
located in the first place, i.e. the first cassette. Likewise, it is reduced when there are preceding 
cassettes (Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995; Ploy, M.C., et al, 2000). 
In effect, when various cassette configurations are present, several RNA transcripts can be 
detected, with different lengths. From the lenghth of the most abundant transcripts, it has become 
evident that they terminate near the 59be end of individual cassettes, which suggests that the 
59be may also act as transcription terminators (Levesque, C., et al, 1994; Collis, C.M. and Hall, 
R.M., 1995).   
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1.6  Conjugative Transposons in Gram-Negative Bacteria 
Conjugative transposons are DNA elements that can excise themselves to form a 
covalently closed circular intermediate (Salyers, A.A., et al, 1995). Subsequently, this 
intermediate can reintegrate itself within the same organism, or it can be transfered by 
conjugation to a recipient cell and then integrate in the recipient’s genome (Salyers, A.A., et al, 
1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall, R.M., 2003). These integrative 
molecular elements were first found in Gram-positive bacteria such as the streptococci and 
enterococci (Tolmasky, M.E., 2000), and were barely mentioned before 1996 in connection with 
Gram-negative bacteria (Pembroke, J.T., et al, 2002). Conjugative transposon-like elements were 
later detected in Gram-negative bacteria, such as Bacteroides spp. (Salyers, A.A., et al, 1995; 
Pembroke, J.T., et al, 2002), and though characterized to a lesser extent, in the 
Enterobacteriaceae. Conjugative transposon-like elements have been reported in Salmonella 
spp., Proteus spp., in the SXT element in Vibrio spp. and in the element known as R391 
(Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall, R.M., 2003).  
Gram-negative conjugative transposons differ considerably from those of Gram-positive 
organisms (Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall, 
R.M., 2003). Some distinguishing features are that they generally are larger than Gram-positive 
conjugative transposons and they carry genes which are derived from diverse sources. In fact, 
they resemble what would be an intermediate between a phage and a plasmid, or “phagemid”. 
However, this denomination has been avoided to prevent confusing them with the genetically 
engineered elements (Pembroke, J.T., et al, 2002).  
Gram-negative conjugative transposons have a broad host range, which gives them a key 
role in the dissemination of antibiotic resistance genes among these bacteria (Salyers, A.A., et al, 
1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall, R.M., 2003). Many conjugative 
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transposons are also able to mobilize plasmids, so the resitance genes do not need to be coded on 
the conjugative transposon themselves in order to be transferred (Salyers, A.A., et al, 1995).   
STX is a conjugative integrating element derived from Vibrio cholerae (Beaber, J.W., et 
al, 2002b; Pembroke, J.T., et al, 2002). Genomic and functional research done on this integrating 
antibiotic resistance gene transfer element has provided insight on the structure of conjugative 
transposons. Another such structure, known as R391, has also provided a basis to define the 
genetic structure of these resistance gene mobilization determinants (Beaber, J.W., et al, 2002a; 
Pembroke, J.T., et al, 2002). Interestingly, conjugative transposons are thought to be related to 
enteric pathogenicity islands in the Enterobacteriaceae (Pembroke, J.T., et al, 2002). 
1.7  16S rRNA Methylases 
As mentioned before, one of the modes of acquisition of aminoglycoside resistance 
through alteration of the target site involves the enzymatic methylation of the 16S rRNA (Carter, 
A.P., et al, 2000; Pfister, P., et al, 2003; Vakulenko, S.B. and Mobashery, S., 2003). This mode 
of ribosomal protection, involving the production of 16S rRNA methylase enzymes, was 
previously detected and reported only in aminoglycoside-producing actinomycetes (Thompson, 
J., et al, 1985; Cundliffe, E., 1989). Recently, however, this mode of resistance has also been 
reported in Gram-negative organisms such as Pseudomonas aeruginosa (Yokoyama, K., et al, 
2003; Yamane, K., et al, 2004), Serratia marcescens (Doi, Y., et al, 2004), and, more relevant to 
this study, members of the Enterobacteriaceae (Galimand, M., et al, 2003; Yamane, K., et al, 
2005). This type of modification is clinically important, since it confers high-level resistance to a 
broad range of aminoglycosides, whereas aminoglycoside-modifying enzymes are substrate-
specific, so they don’t confer resistance to different types of aminoglycosides (Shaw, K.J., et al, 
1993; Miller, G.H., et al, 1997; Galimand, M., et al, 2003; Vakulenko, S.B. and Mobashery, S., 
2003). 
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So far the discussion has centered on the mechanisms of Gram-positive organisms and 
aminoglycoside producers to resist high-levels of these antibiotics. In effect, until recently there 
had been no reports, to the best of our knowledge, of the acquisition of genes confering high-
levels of resistance to aminoglycosides in Gram-negative organisms (Galimand, M., et al, 2003). 
In the first stages of our studies, we had hypothesized that we would find a second gene which 
could act in synergy with the already identified aac(3)IIa gene product to confer high-level 
gentamicin resistance to several members of the Enterobacteriaceae isolated in our laboratories 
and which displayed the HLGR phenotype (Diaz, M.A., et al, 2000).   
Recently, however, a group of investigators from the Pasteur Institut in Paris, published a 
study that has reoriented our research. In brief, M. Galimand (Galimand, M., et al, 2003) found 
that the high-level aminoglycoside resistance in a clinical strain of Klebsiella pneumoniae was 
due to both the presence of the aac3-II gene as well as to a new aminoglycoside resistance 
methylase gene: armA. The enzyme encoded by the latter, ArmA, reportedly shares 37-47% 
similarity with the 16S rRNA m(7)G methyltransferases from various actinomycetes (Galimand, 
M., et al, 2003). In this study, these investigators demonstrated that methylation of 16S rRNA 
can confer high-level resistance to a broad-range of aminoglycosides in Gram-negative 
organisms, including the pathogen they studied. In addition, the same clinical strain of Klebsiella 
pneumoniae also had genes blaTEM1, blaCTX-M, dfrA12, sul1 and ant(3")9, which conferred 
resistance to beta-lactams, trimethroprim, sulfonamides and streptomycin-spectinomycin, 
respectively. Interestingly, the gene armA has a low GC content, making it improbable that this 
gene originated from aminoglycoside-producing actinomycetes (Galimand, M., et al, 2003).   
Concurrently in Japan, a group of researchers (Yokoyama, K., et al, 2003) cloned and 
reported an aminoglycoside-resistance gene, rmtA, from a clinical isolate of Pseudomonas 
aeruginosa AR-2. The enzyme encoded by this gene, RmtA, confers high-level resistance to 
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various aminoglycosides, with a MIC>1024 mg/L (Yokoyama, K., et al, 2003). The enzyme was 
shown to be a methylase as it was able to incorporate radiolabeled methyl groups into the 30S 
ribosome. As opposed to ArmA, this newly identified enzyme showed both sequence and 
functional similarities to the 16S rRNA methylases of aminoglycoside-producing actinomycetes 
(Yokoyama, K., et al, 2003; Yamane, K., et al, 2004; Yamane, K., et al, 2005). Also, the G+C 
content of the rmtA gene is about 55%, which is similar to aminoglycoside-producing organisms. 
Thus, these studies support a possible horizontal gene transfer from aminoglycoside-producing 
microorganisms to P. aeruginosa (Yokoyama, K., et al, 2003; Yamane, K., et al, 2004; Yamane, 
K., et al, 2005). In fact, it has been proposed that gene rmtA may have been transferred by a 
mobile genetic element such as Tn5041 (Yamane, K., et al, 2004; Yamane, K., et al, 2005).   
Recently, another 16S rRNA methylase was isolated in Japan (Doi, Y., et al, 2004). This 
plasmid-borne methylase was isolated from Serratia marcescens and confers high-level 
resistance to aminoglycosides, including the kanamycins and gentamicins. The enzyme shares 
82% identity with RmtA, so it was named RmtB (Yokoyama, K., et al, 2003; Doi, Y., et al, 
2004; Yamane, K., et al, 2005). Its origin is also suspected to be from aminoglycoside producing 
organisms (Doi, Y., et al, 2004; Yamane, K., et al, 2005). Interestingly, ribosomal methylase 
genes have also been detected, encoded as gene cassettes, in a culture-independent gene cassette 
screening study (Nield, B.S., et al, 2004).  
1.8  Objectives 
The objectives of this study were to identify the gene or genes that contribute to high-
level gentamicin resistance in bacteria isolated from environmental samples with turtle farming 
activity in Louisiana, and to determine their incidence in these bacteria, particularly Salmonella 
spp. Additionally, to explore the molecular elements that contribute to the dissemination of 
gentamicin resistance among bacteria isolated at the turtle farms. 
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1.9  Relevance of Study 
The work presented in this thesis is among the first to report high-level gentamicin 
resistance in Gram-negative bacteria. It constitutes one of the first reports of aminoglycoside 
resistance genes aac(3)IIa and aac(3)VIa in environmental isolates of Salmonella enterica subsp. 
arizonae. Additionally, this study illustrates the potential of transfer of antibiotic resistance 
genes, particularly gentamicin resistance, among bacteria in an environment with turtle farming 
activity, a matter of particular concern as it involves the zoonotic pathogen Salmonella spp.  
This research provides epidemiological data describing the resistance to aminoglycosides 
currently used both in the turtle farms and in the clinical setting. The data presented highlights 
the current inefficacy of the antibiotic gentamicin to eradicate Salmonella spp. from turtle eggs. 
We hope to persuade the relevant authorities in Louisiana to revise the mandate to use 
gentamicin for turtle egg treatment and to stress the need to develop new treatments to eradicate 
Salmonella from turtle hatchlings.   
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2.1  Introduction 
Turtle farming has been an important economic activity in the state of Louisiana since 
the 1930s (Siebeling, R.J., et al, 1975b). The sale of small carapace turtles, Pseudemys 
(Trachemys) scripta elegans, was banned in 1975 in the United States’ domestic pet market by 
the FDA due to concerns about their excretion of the human pathogen Salmonella spp. 
(Siebeling, R.J., et al, 1975a; Cohen, M.L., et al, 1980; Shane, S.M., et al, 1990). Estimates in 
the 1970s indicated that approximately 3x105 cases of human salmonellosis could be traced to 
pet turtles (Siebeling, R.J., et al, 1975a; Cohen, M.L., et al, 1980), reportedly accounting for 
14% of Salmonella spp. infections per year (Cohen, M.L., et al, 1980). In spite of the domestic 
ban on the sale of baby turtles, the export market has continued to thrive. Around 12 million 
hatchlings enter the export market each year to Western Europe, South America and Asia 
(Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984; Izadjoo, M.J., et al, 1987). Prior to 
export, hatchlings must be certified Salmonella-free by independent FDA-approved 
laboratories (Siebeling, R.J., et al, 1984). This test involves enrichment and isolation of 
Salmonella spp. by classic bacteriological assays performed on representative turtle samples 
obtained at the farms (Siebeling, R.J., et al, 1975b; Siebeling, R.J., et al, 1975a; Siebeling, R.J., 
et al, 1984). In order to eradicate Salmonella spp. from turtle eggs, turtle farms follow a 
modified version of the protocol used in the turkey farm industry to treat eggs, known as the 
pressure-differential gentamicin egg-dip procedure (Saif, Y.M. and Shelly, S.M., 1973; 
Greenfield, J., et al, 1975; Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). This FDA-
approved treatment involves cleaning fresh-picked eggs by immersing them in a 380 ppm 
Clorox bath and next treating them in a gentamicin sulfate (Garasol; Shering Corp., 
Bloomfield, N.J.) solution at 1000 ppm (µg/ml) (Siebeling, R.J., et al, 1975b; Michael-Marler, 
S., et al, 1983; Siebeling, R.J., et al, 1984). The use of gentamicin for the treatment of turtle 
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eggs presents various advantages at a commercial turtle farm level, since it does not lose its 
antimicrobial activity when in solution or when exposed to freezing or autoclaving 
temperatures (Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984).  
Gentamicin belongs to the aminoglycoside family of antibiotics. The two major classes 
of 2-deoxystreptamine aminoglycosides are the 4,5-disubstituted molecules, which include 
neomycin, paramomycin, and ribostamycin, and the 4,6-disubstituted molecules, which include 
gentamicin, kanamycin and amikacin (Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; 
Vakulenko, S.B. and Mobashery, S., 2003). Aminoglycosides are highly-potent, broad-
spectrum, bactericidal antibiotics that are often used in combination therapy with cell wall 
active agents to treat infections caused by Gram-positive organisms such as Staphylococcus 
aureus and streptococci (Miller, G.H., et al, 1997; Wright, G.D., et al, 1998; Vakulenko, S.B. 
and Mobashery, S., 2003) as well as intracellular bacteria (Maurin, M. and Raoult, D., 2001; 
Vakulenko, S.B. and Mobashery, S., 2003). Gram-negative aerobic bacilli are also sensitive to 
these antibiotics, which makes them a treatment of choice for these infections (Wright, G.D., et 
al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Aminoglycoside antibiotics act by 
inhibiting prokaryotic protein synthesis (Davis, B.D., 1987; Mazel, D. and Davies, J., 1999). 
They induce misreading of the genetic code by binding to the 16S ribosomal RNA A-site in 
bacteria (Moazed, D. and Noller, H.F., 1987; Carter, A.P., et al, 2001). The most important 
mechanism of aminoglycoside resistance is the enzymatic modification of the antibiotic by 
aminoglycoside modifying enzymes, which are divided according to their enzymatic activity 
into the aminoglycoside phosphoryltransferases (APHs), the aminoglycoside 
nucleotidyltransferases (ANTs) and the aminoglycoside acetyltransferases (AACs) (Davis, 
B.D., 1987; Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, 
S., 2003). In spite of the resistance problems that have arisen since the early 1970s and their 
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relatively high toxicity to the host, they are still antibiotics of clinical choice, especially in 
combined therapeutic use with β-lactams (Miller, G.H., et al, 1997; Wright, G.D., et al, 1998; 
Vakulenko, S.B. and Mobashery, S., 2003).  
Antibiotic use constitutes a selective pressure which can ultimately result in the 
emergence of resitant strains; thus, bacteria resistant to a particular antibiotic are often detected 
following its implementation or use (Davies, J. and Smith, D.I., 1978; Miller, G.H., et al, 1997; 
Levy, S.B., 1998; Mazel, D. and Davies, J., 1999). Gentamicin resistance in Salmonella spp. 
isolated from pet turtles was originally reported in Canada, in a 1990 study stating that turtles 
imported from Louisiana carried gentamicin-resistant Salmonella spp. (D'Aoust, J.Y., et al, 
1990). Concerns of the emergence of gentamicin-resistant Salmonella enterica subsp. arizonae 
which could survive gentamicin treatment had been previously reported in the turkey farm 
industry (Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). In July of 1999, several 
Louisiana pet turtle export shipment lots failed certification. We received bacterial isolates 
from failed-lot turtle samples from the certification laboratory, and we detected strains that 
were resistant to concentrations of gentamicin >2000 µg/ml. The goal of the present study was 
to identify the gene or genes which contribute to the high-level gentamicin resistance 
phenotype observed in enteric bacteria, particularly Salmonella spp., from environmental 
samples with turtle farming activity in Louisiana, and to determine the incidence of such genes 
in the turtle farm environment.  
2.2  Materials and Methods 
2.2.1. Sample Recovery, Bacterial Isolation and Identification 
The main geographical areas in Louisiana where turtle farming is conducted are Pierre 
Part, Jonesville and Ponchatoula (Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984; 
Izadjoo, M.J., et al, 1987). Samples were taken from various commercial pet turtle farms in 
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Louisiana during the egg-laying season (April through September), from 1999 to 2002. 
Samples were individually taken at different steps of the egg sanitation process, since each step 
involved different exposures to gentamicin (GEN): 1) turtle hatchlings which had failed the 
Certification assay (i.e., they were excreting Salmonella spp.) and which were provided by 
Central Analytical Laboratories, Belle Chase, LA (Siebeling, R.J., et al, 1975a; Michael-
Marler, S., et al, 1983); 2) eggs, which were collected directly from dirt nests and which had 
not yet been treated with GEN; 3) the 1000 µg/ml GEN solution used to treat eggs and 4) water 
from pet turtle farm ponds. Each sample was taken separately and only one isolate of each 
genus and species was recovered per sample, to avoid double inclusion of the same isolate. 
Samples were enriched for Salmonella spp. using selenite cistine broth (Difco, Detroit, MI), 
and isolated on bismuth sulfite (Difco) plates as previously described (Siebeling, R.J., et al, 
1975a; Siebeling, R.J., et al, 1984). Gram-negative bacteria were routinely grown at 37oC using 
McConkey (Difco) plates. Isolates were identified using API-20E or API-NE (bioMérieux SA, 
Marcy l'Etoile, France). Conjugation assays were done using Heart Infusion (HI) media 
(Difco). Laboratory strains were grown using Luria-Bertani (LB) media (Sambrook, J., et al, 
1989). All GEN-resistant strains were propagated in media supplemented with 100 µg/ml GEN. 
A summary of all laboratory bacterial strains and plasmids used in this study is found in Table 
2.1. 
2.2.2. Antibiotic Susceptibility Assays 
The minimal inhibitory concentration (MIC) assays were performed in microdilution plates, 
using Mueller-Hinton (MH) broth (Difco), following the procedure recommended by the 
National Committee for Clinical Laboratory Standards (NCCLS) (NCCLS, 1999), using the 
following aminoglycoside antibiotics: GEN, kanamycin (KAN), streptomycin (STR), neomycin 
(NEO), tobramycin (TOB), amikacin (AMK), netilmicin (NET) and sisomicin (SIS) (Sigma, St.  
Table 2.1.  Bacterial Strains and Plasmids Used in This Study 
Strain or plasmid Relevant characteristics Source or Reference 
Laboratory strains   
E. coli TOP10 Electrocompetent or chemically competent. F- 
mcrA ∆(mrr-hsdRMS-mcrBC) 
Ф80lacZ∆M15 ∆lacX74 recA1 deoR 
araD139 (ara-leu)7697 galU galK rpsL (Strr) 
endA1 nupG  
GENs (MIC: <3.9 µg/ml) 
Invitrogen 
E. coli strain BM14 AZI; GENs (MIC: <3.9 µg/ml) 8 
Environmental strains   
S. enterica subsp. enterica, 
strain S5 
GEN KAN TOB; GEN MIC: >2000 µg/ml  turtle nest eggs a 
 
S. enterica subsp. arizonae, 
strain A40 
GEN KAN TOB; GEN MIC: >2000 µg/ml  infected turtles b 
 
S. enterica subsp. arizonae, 
strain PH5 
GEN KAN TOB; GEN MIC: >2000 µg/ml  turtle pond water c 
 
E. cloacae, strain E19 
 
GEN KAN TOB; GEN MIC: >2000 µg/ml  infected turtles b 
 
C. freundii, strain C14 GEN KAN TOB; GEN MIC: >2000 µg/ml  turtle nest eggs a 
Plasmids   
  pGEM®-7Zf cloning and sequencing vector; AMP Promega 
  pCR2.1-TOPO cloning and sequencing vector; KAN Invitrogen 
  
(table cont’d)
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  pSal5 R-plasmid isolated from S. enterica subsp. 
enterica, strain S5 
this study  
  pAri40 R-plasmid isolated from S. enterica arizonae, 
strain A40 
this study  
  pAriPH5 R-plasmid isolated from S. enterica subsp. 
arizonae, strain PH5 
this study  
  pEnt19 R-plasmid isolated from E. cloacae, strain E19 this study  
  pCit14 R-plasmid isolated from C. freundii, strain C14 this study 
  pGSal5h pGEM®-7Zf derivative containing a 5.5 kb 
HindIII fragment from pSal5  
this study 
  pGEnt19b pGEM®-7Zf derivative containing a 5.0 kb 
BamHI fragment from pEnt19  
this study 
a isolated from nest egg homogenate (26, 37, 38) at the Louisiana turtle farms, July 1999; b supplied by 
Central Analytical Laboratory, Belle Chase, LA, July 1999, c isolated from turtle breeding pond water 
in Louisiana, June 2000. Abbreviations: AMP, ampicillin; AZI, sodium azide; GEN, gentamicin; 
GENs, gentamicin sensitive; KAN, kanamycin; TOB, tobramycin.  
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Louis, MO). In all cases, the starting antibiotic concentration tested was 2000 µg/ml serially 
diluted two-fold to 3.9 µg/ml.  
The Kirby-Bauer disk-diffusion assay was performed using MH agar plates according 
to NCCLS standards (NCCLS, 1999); using the following antibiotics: GEN (10 µg), KAN (30 
µg), TOB (10 µg), AMK (30 µg), ampicillin (AMP) (10 µg), tetracycline (TET) (30 µg), 
chloramphenicol (CHL) (30 µg), polymixin B (PMB) (300 units), cephalothin (CEF) (30 µg), 
cefotaxime (CTX) (30 µg), trimethoprim (TMP) (5 µg) and nitrofurantoin (NIT) (300 µg) 
(Difco). Inhibition zone breakpoints were interpreted according to information supplied by the 
manufacturer and to NCCLS standards (NCCLS, 1999).  
2.2.3. R-Plasmid Isolation and Characterization 
Conjugation was done to detect plasmids carrying GEN-resistance determinants. In 
each bacterial mating experiment, a GEN-resistant organism was used as the donor. 
Representative isolates of each genus and species (chosen based on similar resistance 
phenotypes) were used as donors and included S. enterica subsp. enterica serovar Enteritidis, S. 
enterica subsp. arizonae, E. cloacae, C. freundii, P. aeruginosa, Acinetobacter baumanii, 
Stenotrophomonas maltophilia, Proteus vulgaris and Providencia stuartii. E. coli strain BM14, 
resistant to sodium azide (AZI) was used as the recipient (Cloeckaert, A., et al, 2000). Bacterial 
mating was done by mixing 1 ml of a log-phase culture of GEN-resistant donor cells with 4 ml 
of log-phase recipient AZI-resistant E. coli BM14 cells and incubating at 37°C for 16 hours, 
with no shaking. Transconjugant AZI-resistant, GEN-resistant E. coli colonies were selected on 
HI plates supplemented with 100 µg/ml GEN and 500 µg/ml AZI.  
R-plasmids from GEN-resistant bacteria were purified using QIAfilter plasmid kits 
(Qiagen, Valencia, CA), following instructions provided by the manufacturer for low copy 
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number plasmids. Plasmids were eluted in molecular grade water at 65oC and stored at -20oC. 
To minimize the possibility of working with strains carrying more than one plasmid 
(mobilizable plasmids that might co-transfer during conjugation) and to better assess the 
resistance phenotypes (AZI-resistant transconjugant E. coli have a slower growth rate), 
plasmids isolated from transconjugants were used to transform naïve OneShot TOP10 E. coli 
cells (Invitrogen, Carlsbad, CA), using a Bio-Rad Gene Pulser II electroporator (BioRad, 
Hercules, CA), following recommendations from the manufacturer. Briefly, 50 µl 
electrocompetent cells were transferred to a chilled 0.1 cm cuvette with 1-2 µl of diluted 
plasmid DNA. Pulses were given at 2.0 kV, 25 µF and 100-200 Ω for 5 msec. Transformant 
GEN-resistant E. coli cells were selected on LB plates supplemented with 100 µg/ml GEN.  
To compare their restriction fragment profiles, R-plasmids were isolated as described 
above from environmental GEN-resistant isolates, transconjugant E. coli, and transformant E. 
coli cells. DNA concentration of uncut plasmids was estimated by comparison to Supercoiled 
Plasmid DNA ladder (Bayou Biolabs, Harahan, LA), after 0.5% Agarose I (Sigma) in 0.5x 
TBE (BioRad) gel electrophoresis migration. R-plasmids were digested separately with EcoRI, 
HindIII or BamHI (New England Biolabs, Beverly, MA), following recommendations from the 
manufacturer for each restriction enzyme. Restriction enzyme digestion profiles were assessed 
using 0.5% agarose III (Amresco, Solon, OH) gel electrophoresis in TAE buffer (Sambrook, J., 
et al, 1989). The 1 kb DNA ladder and λ DNA-Hind III Digest (New England BioLabs) were 
used as molecular size standards. Image analysis was done by UV transillumination of ethidium 
bromide-stained gels using the Quantity One imaging software (BioRad).  
The sizes of the large R-plasmids were estimated using Pulse Field Gel Electrophoresis. 
Briefly, 0.8% Pulse Field Electrophoresis Agarose (Sigma) plugs were made with R-plasmids 
isolated as described above. Agarose plugs were loaded onto a 90 ml, 1% agarose (Sigma) gel 
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in 0.5x TBE buffer and run in 0.5x TBE buffer using a CHEF–DR II system (BioRad). 
Electrophoresis was run for 22 h at 6 V/cm, 120o and 14ºC with switch times ramping 1-25 
seconds. The Midrange I PFG Marker (New England BioLabs) and the BAC-TrackerTM 
Supercoiled DNA Ladder (Epicentre Biotechnologies, Madison, WI) were used as a molecular 
size standards. Image analysis was done after staining with ethidium bromide, using Quantity 
One imaging software. 
2.2.4. Cloning and Identification of GEN-Resistance Gene(s) 
A vast number of genes are known to confer GEN resistance in Gram-negative bacteria 
(Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). 
To determine which gene(s) confer GEN resistance in the isolates of this study, these were 
cloned and sequenced as follows: R-plasmids isolated as described above were digested with 
EcoRI, HindIII or BamHI, according to the manufacturer’s recommendations. Restriction 
fragments were purified using QIAquick Spin columns (Qiagen) and ligated into previously 
digested pGEM®-7Zf (Promega, Piscataway, NJ). Ligation reactions were used to transform E. 
coli TOP10 chemically competent cells (Invitrogen) following the protocol provided by the 
manufacturer. Recombinant clones carrying GEN-resistance determinants were selected on LB 
plates supplemented with 100 µg/ml GEN and 50 µg/ml AMP. Recombinant plasmids were 
purified with QIAprep Spin columns (Qiagen) and inserts were sequenced using the vector’s 
internal sequencing primers. 
2.2.5. Sequencing and Computer Analysis 
Sequencing was done with fluorescent dye-labeled dideoxynucleotides with an ABI 
Prism 310 Genetic Analyzer (Applied Biosystems, Foster City, CA). Sequence analysis was 
done using VectorNTI (Invitrogen), BLAST (Altschul, S.F., et al, 1997) and GeneBank 
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(National Center for Biotechnology Information, available through 
http://www.ncbi.nlm.nih.gov/BLAST/). 
2.2.6. Screening for GEN Resistance Genes 
Multiplex PCR assays were designed to screen environmental isolates for the GEN-
resistance genes that were identified through cloning and sequencing of GEN resistance 
determinants. Multiplex PCR reactions included primers to detect resistance genes aac(3)IIa 
and aac(3)VIa, as well as a fragment of the 16S rRNA gene as an internal control for each 
reaction (Vliegenthart, J.S., et al, 1990). Primers were designed using Vector NTI (Invitrogen). 
PCR screening of genes intI and sul1, commonly associated with class 1 integrons (Stokes, 
H.W. and Hall, R.M., 1989; White, P.A., et al, 2001), and of armA, rmtA and rmtB, the only 
genes reported to confer high level aminoglycoside resistance in Gram-negative bacteria 
(Yamane, K., et al, 2005), was done in separate reactions using published primers (Schwocho, 
L.R., et al, 1995; Sunde, M. and Sorum, H., 1999; Galimand, M., et al, 2003; Yokoyama, K., et 
al, 2003; Doi, Y., et al, 2004; Yamane, K., et al, 2005). All primers used are summarized in 
Table 2.2. To prepare DNA for PCR, pelleted cells from 1 ml of overnight cultures were 
resuspended in 100 µl dH2O and lysed through two 5 min. freeze-boil cycles. 2 µl of the 
supernatants were used as templates in 50 µl PCR reactions. PCR was done using the 
FailSafe™ PCR System with buffer “G” (Epicentre Biotechnologies) according to instructions 
provided by the manufacturer. Thermocycler conditions were set as follows: [1X (96oC, 5 min); 
35X (96oC, 30 sec; 58oC, 30 sec; 70oC, 60 sec); (70oC, 7 min)]. To amplify the armA gene, 
PCR was done using the same conditions stated above, but various annealing temperatures 
(40oC, 42.2oC, 44.1oC, 46.9oC, 48.9oC, 50.2oC and 51oC) were assayed in different reactions. 
PCR products were visualized by agarose gel electrophoresis using 2% Agarose I in 0.5x TBE 
buffer and staining with ethidium bromide. Some PCR products were sequenced to confirm 
 
 
Table 2.2.  Primers Used for PCR and Sequencing 
PCR target  Primer Amplicon size (bp) Sequence (5' → 3') 
Accession No. 
(Reference) 
aac(3)-IIa aacIIaF 900 GGG AAT TCA GAG GAG ATA TCG CGA TGC ATA CG X13543 (*) 
 aacIIaR  CAT TGT CGA CGG CCT CTA ACC  
aac(3)-VIa aacVIaF 465 CGC TCA GGC GAT ATG GTG AT L22613 (*) 
 aacVIaR  CAT AAT GGA GCG CGG TGA CT  
armA metF 777 CAA ATG GAT AAG AAT GAT GAT GAT AY220558 (18) 
 metR  TTA TTT CTG AAA TCC ACT  
rmtA RMTA-F 634 CTA GCG TCC ATC CTT TCC TC AB083212 (46) 
 RMTA-R  TTT GCT TCC ATG CCC TTG CC  
rmtB MBH-F 771 GGA ATT CCA TAT GAA CAT CAA CGA TGC CCT AB103506 (13) 
 MBH-R  CCG CTC GAG TCC ATT CTT TTT TAT CAA GTA  
intI1 intIF 845 CTA CCT CTC ACT AGT GAG GGG CGG X15852 (34,40)
 intIR  GGG CAG CAG CGA AGT CGA GGC  
sul1 sulF1 840 ATG GTG ACG GTG TTC GGC AT U12441 (18,40)
 sulR  CTA GGC ATG ATC TAA CCC TC  
rrn rrn1A 330 TAA CAC ATG CAA GTC GAA CG (43) 
 rrn2B  CCC ATT GTG CAA TAT TCC CC  
 M13F (-20) variable GTA AAA CGA CGG CCA G (Invitrogen) 
 M13R  CAG GAA ACA GCT ATG AC  
 
* E.C. Achberger, personal communication 
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amplification of the appropriate genes and to compare with published sequences in the 
databases. For sequencing, PCR products were purified using QIAquick Spin columns and 
ligated into pCR2.1-TOPO using the TOPO-TA cloning kit (Invitrogen), as suggested by the 
manufacturer. Sequencing of appropriate clones was done using the internal vector sequencing 
primers, as described above.  
2.3  Results 
2.3.1. Gentamicin Resistance in Turtle Farms 
Bacterial genera and species recovered from the turtle farm setting are summarized in 
Table 2.3, and they include S. enterica subsp. enterica, S. enterica subsp. arizonae, E. cloacae, 
C. freundii, P. aeruginosa, A. baumanii, S. maltophilia, A. faecalis, P. vulgaris and P. stuartii. 
The antibiotic resistance phenotypes of the organisms tested show that in addition to resistance 
to GEN, these organisms exhibited resistance to other aminoglycosides such as KAN and TOB, 
but not to AMK. Some organisms were also resistant to AMP (Table 2.3). Organisms such as 
P. aeruginosa and S. maltophilia were resistant to the majority of the antibiotics assayed.  
As summarized in Table 2.3, the majority of GEN-resistant bacteria displayed high-
level resistance to GEN (MIC>2000 µg/ml). GEN-sensitive bacteria were primarily recovered 
from untreated eggs and breeding ponds and presented GEN MICs from <3.9-7.8 µg/ml (Table 
2.3), whereas the majority of isolates recovered from contaminated turtles and the GEN dip 
solutions showed elevated resistance to GEN. Nevertheless, GEN-resistant isolates recovered 
from untreated eggs and breeding ponds also expressed high-level of resistance. E. coli strain 
BM14, E. coli OneShot TOP10, and E. coli ATCC 25922, used as GEN-sensitive controls, had 
GEN MICs <3.9-7.8 µg/ml (Table 2.1). 
  
Table 2.3.  Prevalence of Gentamicin Resistance Genes Among Bacterial Isolates From Turtle Farms 
Number GENr GEN MIC % Incidence d Samplea  Identifed organism collected n (%) Resistance phenotype
 b (µg/ml) c aac(3)IIa aac(3)VIa
        
Pond water Citrobacter freundii 43 7 (16) GEN KAN TOB >2000  43 57 
 Enterobacter cloacae 20 3 (15) GEN KAN TOB >2000  - 100 
 Pseudomonas aeruginosa 4 2 (50) GEN KAN TOB AMP 
(CHL) (CTX) NIT (TET) 
TMP 
>2000  100 - 
 S. enterica subsp. arizonae 38 4 (11) GEN KAN TOB >2000  - 100 
 Stenotrophomonas maltophilia 7 3 (43) GEN KAN TOB AMP 
(CHL) (CTX) NIT (TET) 
TMP 
>2000  100 - 
        
Nest eggs Citrobacter freundii 49 6 (12) GEN KAN TOB >2000  33 67 
 Enterobacter cloacae 44 2 (5) GEN KAN TOB >2000  - 100 
 Escherichia coli 3 1 (33) GEN KAN TOB >2000  - 100 
 Proteus vulgaris  1 1 (100) GEN AMP NIT PMB 
(TMP) 
500  100 - 
 Pseudomonas aeruginosa 12 5 (42) GEN KAN TOB AMP 
(CHL) (CTX) NIT (TET) 
TMP  
>2000  100 - 
 S. enterica subsp. enterica 4 2 (50) GEN KAN TOB >2000 100 - 
 S. enterica subsp. arizonae 53 11 (21) GEN KAN TOB >2000  - 100 
        
GEN soln. Acinetobacter baumannii 1 1 (100) GEN KAN TOB AMP TMP >2000  100 - 
 Alcaligenes xylosoxidans 2 2 (100) GEN KAN TOB AMP 
(CHL) CTX NIT TET TMP
>2000  100 - 
 Pseudomonas aeruginosa 3 3 (100) GEN KAN TOB AMP 
(CHL) CTX NIT TET TMP
>2000  100 - 
 
 
(table cont’d) 
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 Pseudomonas fluorescens 2 2 (100) GEN KAN TOB AMP (CHL) 
(CTX) NIT (TET) TMP 
>2000  100 - 
        
Turtles Alcaligenes faecalis 1 1 (100) GEN KAN TOB AMP TMP >2000  100 - 
 Citrobacter freundii 4 4 (100) GEN KAN TOB >2000  - 100 
 Enterobacter cloacae 3 3 (100) GEN KAN TOB >2000  - 100 
 Escherichia  coli 1 1 (100) GEN KAN TOB >2000  - 100 
 Proteus vulgaris  2 2 (100) GEN AMP NIT PMB (TMP) 500  100 - 
 Providencia stuartii 3 3 (100) GEN AMP NIT PMB (TMP) 500  100 - 
 Pseudomonas aeruginosa 8 5 (63) GEN KAN TOB AMP (CHL) 
(CTX) NIT (TET) TMP 
>2000  100 - 
 S. enterica subsp. arizonae 28 28 (100) GEN KAN TOB >2000  - 100 
        
a Samples were taken from nest egg homogenate, turtle breeding pond water and GEN soln., as previously described (26, 37, 
38), at turtle farms in Louisiana, 1999-2002. Infected turtle isolates were supplied by Central Analytical Laboratory, Belle 
Chase, LA, July 1999. b Resistance phenotype and c MIC value displayed by >90% of GEN resistant isolates, for each genus 
and species. GEN sensitive isolates presented GEN MIC <3.9-7.8 µg/ml. d % GEN resistant strains carrying aac(3)IIa or 
aac(3)VIa. Abbreviations: AMP, ampicillin; CHL, chloramphenicol; CTX, cefotaxime; GEN, gentamicin; GENr, GEN 
resistance; GEN soln., GEN egg dip solution (1000 µg/ml); KAN, kanamycin; NIT, nitrofurantoin; PMB, polymixin B; TET, 
tetracycline; TMP, trimethoprim; TOB, tobramycin; antibiotics in parenthesis denote intermediate resistance.  
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2.3.2. R-plasmid Isolation 
When checked for plasmids, environmental GEN-resistant isolates showed one or more 
plasmids. Nevertheless, transconjugant E. coli resistant to GEN and AZI were obtained only 
from the strains of S. enterica subsp. enterica, S. enterica subsp. arizonae, E. cloacae and C. 
freundii. Transconjugants' GEN MICs were all >2000 µg/ml. Likewise, the antibiograms were 
similar between donor organisms and their E. coli transconjugants. Furthermore, OneShot 
TOP10 E. coli cells transformed with R-plasmids isolated from these transconjugants acquired 
the same resistance phenotypes as the transconjugant from which the R-plasmid had been 
isolated. The resulting phenotypes and genotypes of these transformant E. coli are summarized 
in Table 2.4. 
2.3.3. Identification of GEN Resistance Gene(s) 
R-plasmid pSal5 was isolated from GEN-resistant E. coli obtained after transformation 
with plasmids from S. enterica (strain S5) (Table 4). Recombinant plasmid pGSal5h was 
obtained from a 5.5 kb HindIII restriction fragment of pSal5 that was ligated into pGEM®-7Zf. 
Sequence analysis of this GEN-resistant clone revealed the presence of the aminoglycoside 
resistance gene aac(3)IIa, which was 98% identical to that in GenBank database accession no. 
X13543 (Brau, B., et al, 1984; Allmansberger, R., et al, 1985; Vakulenko, S.B. and Mobashery, 
S., 2003). 
Preliminary screening to detect gene aac(3)IIa in other environmental isolates revealed 
that some GEN-resistant organisms did not carry aac(3)IIa. Thus, R-plasmid pEnt19, originally 
from E. cloacae (strain E19) (Table 2.4), was used for cloning and sequencing since this 
plasmid conferred GEN resistance, but did not carry aac(3)IIa. Recombinant plasmid 
pGEnt19b was obtained from a 5 kb BamHI fragment of R-plasmid pEnt19 ligated into
 
Table 2.4.  R-Plasmids Isolated From Bacteria Recovered From Turtle Farms 
 Size RFLP Resistance GEN MIC GEN resistance and integron-associated genes b 
Plasmid (kb) type phenotypea (µg/ml)a aac(3)IIa aac(3)VIa armA rmtA rmtB intI1 sul1
            
pSal5 ca.  45 A GEN KAN TOB >2000      + - - - - - + 
pAri40 ca. 145 B GEN KAN TOB >2000      - + - - - + + 
pAriPH5 ca. 145 B GEN KAN TOB >2000      - + - - - + + 
pEnt19 ca. 115 C GEN KAN TOB >2000      - + - - - + + 
pCit14 ca.  45 D GEN KAN TOB >2000      + - - - - - - 
            
a determined using transformant TOP10 E. coli cells; b as determined by PCR and/or sequencing 
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pGEM®-7Zf. Sequence analysis of pGEnt19b revealed the presence of aminoglycoside 
acetyltransferase gene aac(3)VIa, which was 99% identical to that in GenBank database 
accession no. L22613 (Rather, P.N., et al, 1993). Sequencing and PCR additionally revealed 
integron class 1 associated genes intI1 and sul1 (Table 2.4), indicating the presence of 
aac(3)VIa as a gene cassette of a class-1 integron.  
Genes aac(3)IIa or aac(3)VIa have not been reported in the literature to confer high-
level GEN resistance (Brau, B., et al, 1984; Allmansberger, R., et al, 1985; Rather, P.N., et al, 
1993; Vakulenko, S.B. and Mobashery, S., 2003). We thus attempted to amplify by PCR the 
16S rRNA methylase genes recently reported in the literature which do confer a high-level 
aminoglycoside resistance phenotype in Gram-negative bacteria, namely armA (Galimand, M., 
et al, 2003), rmtA (Yokoyama, K., et al, 2003; Yamane, K., et al, 2004) and rmtB (Doi, Y., et 
al, 2004). Nevertheless, these genes were not detected in the isolates tested (Table 2.4).  
2.3.4. Distribution of GEN Resistance Genes in Bacterial Isolates From Turtle Farms 
Multiplex PCR assays designed to screen for the presence of resistance genes aac(3)IIa 
and aac(3)VIa on bacterial isolates from turtle farms (N=336), revealed that every GEN-
resistant organism tested carried either one of these acetyltransferase genes (Table 3). Gene 
aac(3)IIa was present in 37% of the GEN-resistant isolates tested (n=101); it was detected 
mainly in non-fermentors but was also found in S. enterica subsp. enterica and C. freundii. 
Gene aac(3)VIa accounted for 94% of GEN resistance in Salmonella spp. (n=35). Neither gene 
was detected in GEN-sensitive organisms, including GEN-sensitive controls previously 
described. intI1 was detected by PCR in all GEN-resistant bacteria carrying aac(3)VIa, but not 
in organisms carrying aac(3)IIa.  
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      HindIII                   BamHI  
 1        2        3              4        5        6 kbp 
 23.130 
  9.416 
  6.557 
 
 
 
Figure. 2.1.  HindIII and BamHI digestion profiles of R-plasmids pSal5 
(lanes 1 & 4), pAri40 (lanes 2 & 5) and pEnt19 (lanes 3 & 6).  λ-DNA-Hind 
III digest, used as a molecular standard, is indicated on the left. Arrowheads 
indicate bands carrying genes aac(3)IIa (►) and aac(3)VIa (◄). 
 
  2.322 
  4.361 
  2.027 
►  ◄
   
◄  
 67
2.3.5. Plasmid Heterogeneity 
R-plasmids pSal5, pAri40, and pEnt19 showed different HindIII and BamHI RFLP 
profiles (Figure 2.1). Multiplex PCR of resistance genes aac(3)IIa and aac(3)VIa (Table 2.4) 
plus hybridization of these genes with digested R-plasmids (Figure 2.1) showed that pSal5 
carried aac(3)IIa, and that pAri40 and pEnt19 carried aac(3)VIa, confirming that these genes 
are plasmid-borne. The mentioned R-plasmids differed in size as well, as visualized after PFGE 
and ethidium bromide staining. These results are summarized in Table 2.4. 
2.4  Discussion 
Turtles and other reptiles are known to excrete S. enterica subsp. arizonae and other 
salmonellae (Cohen, M.L., et al, 1980; D'Aoust, J.Y., et al, 1990; Ebani, V.V., et al, 2005). The 
GEN resistance that has emerged in the last decade presents a threat to the efficacy of the GEN 
sulfate treatment used by the turtle industry to eradicate Salmonella spp. In this study, we found 
two genes which are carried by bacteria recovered from environmental samples with turtle 
farming activity which confer high-level GEN resistance. These genes are aac(3)IIa and 
aac(3)VIa, which code for aminoglycoside acetyltransferase enzymes (Brau, B., et al, 1984; 
Allmansberger, R., et al, 1985; Rather, P.N., et al, 1993). Gene aac(3)IIa presents the 
AAC(3)II aminoglycoside resistance pattern phenotype, which involves resistance to GEN, 
TOB, SIS, NET, and DBK (Brau, B., et al, 1984; Allmansberger, R., et al, 1985; Shaw, K.J., et 
al, 1993; Vakulenko, S.B. and Mobashery, S., 2003). These genes are reported to be detected in 
Gram-negative bacteria in the clinical setting with a relatively higher frequency (18-60%) with 
respect to other aminoglycoside resistance patterns (Shaw, K.J., et al, 1993; Miller, G.H., et al, 
1997; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Gene aac(3)IIa, 
originally identified in R-plasmids (Allmansberger, R., et al, 1985), reportedly accounts for 
85% of the AAC(3)-II phenotype (Miller, G.H., et al, 1997; Wright, G.D., et al, 1998; 
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Vakulenko, S.B. and Mobashery, S., 2003). The AAC(3)-VI resistance pattern, includes 
resistance to GEN (Rather, P.N., et al, 1993; Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; 
Vakulenko, S.B. and Mobashery, S., 2003). The gene aac(3)VI was originally cloned from a 
conjugative plasmid of E. cloacae and rarely occurs among clinical isolates (Rather, P.N., et al, 
1993; Vakulenko, S.B. and Mobashery, S., 2003). Its deduced amino acid sequence shares 50% 
amino acid similarity with the aac(3)-IIa gene (Rather, P.N., et al, 1993; Shaw, K.J., et al, 
1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003).  
The majority of aminoglycoside modifying enzymes can provide effective resistance to 
aminoglycosides, but only certain phosphotransferase enzymes detected in Gram-positive 
bacteria have been reported to produce high-levels of resistance to these antibiotics (Ferretti, 
J.J., et al, 1986; Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Chow, J.W., 2000; 
Vakulenko, S.B. and Mobashery, S., 2003). When we started this study there had been no 
reports, to the best of our knowledge, of the acquisition of genes conferring high-level 
aminoglycoside resistance in environmental Gram-negative bacteria (M.A. Diaz, E.C. 
Achberger, V.R. Srinivasan and R.J. Siebeling, Abstr. 100th Amer. Soc. Microbiol. Gen. 
Meeting, abstr. Z-4, 2000). Recently however, Galimand et al (Galimand, M., et al, 2003) 
found that the high-level aminoglycoside resistance phenotype in a clinical strain of Klebsiella 
pneumoniae was due to the presence of the aminoglycoside resistance gene armA. This strain 
of K. pneumoniae also presented genes aac(3)II, blaTEM1, blaCTX-M, dfrA12, sul1 and ant(3")9, 
conferring resistance to aminoglycosides, β-lactams, trimethroprim, sulfonamides and 
streptomycin-spectinomycin, respectively (Galimand, M., et al, 2003). In this study, we did not 
detect gene armA by PCR in any of the isolates screened, in spite of detecting certain shared 
elements in some of the strains, such as genes aac(3)IIa and sul1 (Table 4). We also screened 
for two other high-level aminoglycoside resistance genes: rmtA, cloned and identified from a 
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clinical isolate of P. aeruginosa AR-2 in Japan (Yokoyama, K., et al, 2003) and plasmid-borne 
16S rRNA methylase rmtB, isolated from Serratia marcescens (Doi, Y., et al, 2004). 
Nevertheless, we did not detect by PCR any other resistance gene that could act in synergy with 
the already identified aac(3)IIa or aac(3)VIa gene products or by itself, to give the high-level 
GEN resistance phenotype observed in the bacteria we isolated in the turtle farms. 
The current study is the first to report the genes which confer GEN resistance to 
bacteria in the turtle farm environment, namely aac(3)IIa and aac(3)VIa. PCR and sequencing 
experiments confirmed that these resistance genes are present on mobile genetic elements that 
can facilitate their horizontal transfer among bacteria in the environment (Allmansberger, R., et 
al, 1985; Rather, P.N., et al, 1993; Fluit, A.C. and Schmitz, F.J., 1999; White, P.A., et al, 2001; 
Heuer, H., et al, 2002; Carattoli, A., 2003). Both genes are found on R-plasmids of the 
Enterobacteriacea (Brau, B., et al, 1984; Allmansberger, R., et al, 1985; Rather, P.N., et al, 
1993). Until recently (Galimand, M., et al, 2003), only gene aac(3)VIa had been reported as a 
gene cassette within a class 1 integron (Rather, P.N., et al, 1993; Wright, G.D., et al, 1998; 
White, P.A., et al, 2001; Yamane, K., et al, 2005). Recent studies, however, have also detected 
the aac(3)II gene surrounded by integron elements (Galimand, M., et al, 2003). In fact, the 
molecular environment of armA gene has been depicted as a composite or complex integron 
environment and is found downstream of orf513 coding for a putative recombinase or 
transposase (Partridge, S.R. and Hall, R.M., 2003). We are currently conducting research to 
examine the molecular environment of the genes found.  
GEN-resistant isolates were more prevalent in samples where exposure to GEN was 
greater, but were also detected in turtle pond water and nest eggs, consonant with the notion 
that antibiotic use can favor the selection of resistant strains (Miller, G.H., et al, 1997; Levy, 
S.B., 1998). The presence of these genes on mobile molecular elements can facilitate their 
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transfer and spread among different bacteria in the turtle farm environment (Fluit, A.C. and 
Schmitz, F.J., 1999; Heuer, H., et al, 2002; Carattoli, A., 2003). However, additional studies 
are required to determine if the interspecies dissemination of these genes occurred at the turtle 
farms. This study illustrates the potential of transfer of antibiotic resistance genes, particularly 
GEN resistance, between different genera in the turtle farms, a matter of particular public 
health concern as it involves the human pathogen Salmonella spp. The epidemiological data 
presented stresses the need to develop an alternate method for the eradication of Salmonella 
spp. from turtle eggs. This is the first study to describe the genes involved in GEN resistance in 
S. enterica subsp. arizonae. It is important to monitor the presence of these resistance genes 
and molecular transfer elements in bacteria like the salmonellae, since these cause zoonosis and 
represent possible resistance reservoirs and can thus be important in the development of 
multiresistance in bacteria (Boyd, D., et al, 2002; Carattoli, A., 2003; Ebani, V.V., et al, 2005), 
as well as in its transfer between animals and humans.  
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CHAPTER 3: 
CULTURE-INDEPENDENT IDENTIFICATION OF BACTERIA PRESENT IN 
GENTAMICIN SOLUTIONS USED TO ERADICATE  
SALMONELLA SPP. FROM PET TURTLES 
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3.1  Introduction 
The sale of small turtles, Pseudemys (Trachemys) scripta elegans, has been an 
important economic activity in the State of Louisiana since the 1930s (Siebeling, R.J., et al, 
1975b; Cohen, M.L., et al, 1980). In spite of the domestic ban imposed on the sale of small 
carapace turtles due to salmonellosis outbreaks that were traced back to these pets, the export 
market has continued to thrive (Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984; 
Izadjoo, M.J., et al, 1987). However, in order for baby turtles to be certified for export to 
Europe, Asia and South America, Salmonella spp. must be eradicated from the turtles 
(Siebeling, R.J., et al, 1975a; Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984). For 
this, turtle farms follow a modified version of the FDA-approved pressure-differential 
gentamicin treatment protocol used in the turkey farm industry (Saif, Y.M. and Shelly, S.M., 
1973; Greenfield, J., et al, 1975; Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). In brief, 
turtle eggs are treated in a solution of 1000 ppm (µg/ml) gentamicin by the pressure differential 
method to ensure penetration of the antibiotic into the eggs (Siebeling, R.J., et al, 1975b; 
Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984). The use of the gentamicin sulfate 
solution (Garasol; Shering Corp., Bloomfield, N.J.) was chosen for its practical advantage since 
it has a stable shelf life and can be boiled and filtered, and it retains its bactericidal activity, 
allowing the solution to be stored and reused after appropriate adjustments (Siebeling, R.J., et 
al, 1975b; Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984).  
Gentamicin belongs to the family of the aminoglycosides, which are highly-potent, 
broad-spectrum bactericidal antibiotics, that are commonly used clinically in combination with 
β-lactams for the treatment of Gram-positive organisms such as Staphylococcus aureus and the 
streptococci as well as aerobic Gram-negative infections (Shaw, K.J., et al, 1993; Wright, G.D., 
et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Gentamicin is a 4,6-disubstituted 2-
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deoxystreptamine aminoglycoside (Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, 
S., 2003). Aminoglycoside antibiotics act by inhibiting prokaryotic protein synthesis (Davis, 
B.D., 1987; Mazel, D. and Davies, J., 1999). They induce misreading of the genetic code by 
binding to the 16S rRNA A-site in the bacterial ribosome (Moazed, D. and Noller, H.F., 1987). 
Microorganisms can be intrinsically resistant or become resistant to aminoglycosides through a 
variety of mechanisms, which include: 1) the alteration of the drug’s target through mutational 
or enzymatic modifications of the ribosome; 2) the reduced uptake or accumulation of the drug, 
generally by means of active efflux pumps; and 3) most frequently, the enzymatic modification 
of the antibiotic molecule by aminoglycoside modifying enzymes (Shaw, K.J., et al, 1993; 
Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003).  
In recent years, using a bacteriological culturing approach, we have detected gentamicin 
resistant organisms in commercial turtle farms in Louisiana (Diaz, M.A., et al, in press). 
However, the assessment of the diversity of a microbial community can be largely 
underestimated by these classic culturing techniques (Ward, D.M., et al, 1998; Hengstmann, 
U., et al, 1999), and organisms which may contribute to maintaining the gentamicin resistance 
gene pool in the turtle farms could be missed by conventional antibiotic resistance assays. 
Therefore with this study we intended to identify, using a culture-independent approach, 
organisms present in the 1000 µg/ml gentamicin sulfate treatment solutions used to eradicate 
Salmonella spp. from turte eggs.  
3.2  Materials and Methods 
3.2.1. Sample Collection 
Gentamicin (GEN) treatment solutions were collected in June, 2002 from pet turtle 
farms in five different locations in Louisiana. Samples were collected observing sterile 
conditions. The GEN dip solutions had been used and stored at the farms as usual, for 3-4 days 
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to treat approximately 20,000 turtle eggs. The dip solutions had an original concentration of 
1000 µg/ml GEN, which is recalibrated to this concentration to prior to reuse (Siebeling, R.J., 
et al, 1984). They were kept at 4ºC at the farms, then transported and stored for one year in our 
laboratory at the same temperature. 
3.2.2. DNA Extraction and Purification 
Ten ml of each unfiltered GEN dip solution were centrifuged to pellet any bacterial 
cells present in the treatment solution after the customary year of storage at 4oC. The pellet was 
resuspended in 300 µl saline-EDTA (Sambrook, J., et al, 1989). Cells were lysed by adding 15 
µl of lysozyme (BioRad, Hercules, CA) mixing and incubating for 30 min. at 37°C. This was 
followed by adding 5 µl of Proteinase K (BioRad) and 10 µl SDS (10% w/v) (BioRad) and 
incubating at 60°C for 10 min. and finally, performing 3 freeze–thaw cycles (10 min. at -80°C 
followed by 10 min. at 60°C). 300 µl of the supernatants were stored at -20oC for further 
analysis. The presence of DNA from the lysates was verified on 0.5% agarose I (Sigma, St. 
Louis, MO) gels in 0.5x TBE buffer (BioRad) after staining with ethidium bromide. Image 
analysis was done using the Quantity One imaging software (BioRad). Total community DNA 
was purified using a Prep-A-Gene purification kit (BioRad), according to the manufacturer’s 
instructions. 
3.2.3. Amplification of 16S rRNA Genes From Bacterial Community DNA 
In order to amplify the 16S rRNA genes of the bacterial community in each sample, 
PCR reactions were performed on total community DNA using the universal eubacterial 
primers: 27f (5’-GAG TTT GAT CCT GGC TCA G-3’) and 1525r (5’-AGA AAG GAG GTG 
ATC CAG CC-3’) (Rainey, F.A., et al, 1996). These primers bind to highly conserved 
sequences of the bacterial 16S rRNA gene (Brosius, J., et al, 1978) and produce amplicons of 
1.5 kb. Amplification of the 16S rRNA genes was done using Taq polymerase. PCR reactions 
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were carried out with a Perkin Elmer PCR system 2400 thermocycler (Applied Biosystems, 
Foster City, CA). Briefly, 6 min. of a hot start step at 98oC were followed by 35 cycles with 30 
sec. denaturing at 94oC, 30 sec. primer annealing at 52oC and 60 sec. elongation at 72oC; then a 
final elongation step of 7 min. at 72oC. PCR products were checked by agarose gel 
electrophoresis using 2% agarose I in 0.5x TBE buffer (BioRad) and staining with ethidium 
bromide.  
3.2.4. 16S rRNA Gene Library 
In order to construct a library containing representative clones of the 16S rRNA genes 
of all the bacteria present in each sample (Ward, D.M., et al, 1998; Hengstmann, U., et al, 
1999; Amann, R. and Ludwig, W., 2000), the amplification products obtained with the 
universal eubacterial primers were ligated into pCR 2.1-TOPO (Invitrogen, Carlsbad, CA) 
using the TOPO-TA cloning kit (Invitrogen), as indicated by the manufacturer. Recombinant 
plasmids were transformed into chemically competent TOP10 Escherichia coli cells 
(Invitrogen) and transformants were selected using Luria-Bertani (LB) (Sambrook, J., et al, 
1989) plates supplemented with 50 µg/ml kanamycin (KAN), as recommended by the 
manufacturer. Transformants that grew on LB-KAN plates were picked and grown in LB-KAN 
media for plasmid isolation. 
3.2.5. Amplification of 16S rRNA Genes 
To screen for clones with appropriate insert size, DNA inserts from each of these clones 
were amplified using M13 universal primers (5’- GTA AAA CGA CGG CCA G – 3’ and 5’- 
CAG GAA ACA GCT ATG AC– 3’). Amplification of the 16S rRNA genes was done using 
Taq polymerase. PCR reactions were carried out using a Perkin Elmer PCR system 2400 
thermocycler, with an initial heating step of 3 min. at 94oC, followed by 25 cycles with 30 sec. 
denaturing at 94oC, 30 sec. primer annealing at 52oC and 60 sec. elongation at 72oC; then a 
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final elongation step of 9 min. at 72oC. PCR products were separated on 2% agarose I gels, 
using the 100 bp DNA ladder (Invitrogen) as molecular standards, and visualized after staining 
with ethidium bromide.  
3.2.6. ARDRA 
16S rRNA PCR products were digested using Taq1 for 1 h. at 65°C. Restriction 
fragments were separated in 3.0% GenepureSieve GQA agarose gels (ISC BioExpress) in TBE 
(BioRad). Agarose gels were tempered at 55-60ºC for 25 min. before pouring, then cooled for 
30 min. at room temperature and 30 min. at 5oC, before use. Different restriction fragments 
were analyzed by comparison to DNA Molecular Weight Marker VIII (Roche Diagnostics, 
Basel, Switzerland) using the Bionumerics ARDRA software (Applied Maths, St.-Martens-
Latem, Belgium).  
3.2.7. Partial Sequencing of Selected Clones 
Recombinant plasmids with appropriate sized inserts (1.5 kb) were purified from 
transformant E. coli to use for sequencing, using QIAprep Spin columns (Qiagen, Valencia, 
CA) as recommended by the manufacturer. Clones were sequenced using the 27f primer. 
Automated sequencing was done with fluorescent dye-labeled dideoxynucleotides using an 
ABI PRISM 310 Genetic Analyzer (Applied Biosystems).  
3.2.8. 16S rRNA Gene Sequence Analysis 
The sequence data obtained from the cloned 16S rRNA inserts was used to search 
existing databases for similar 16S rRNA gene sequences, using the Ribosomal Database Project 
(available through http://rdp.cme.msu.edu/) (Maidak, B.L., et al, 2000; Maidak, B.L., et al, 
2001) and BLAST (Altschul, S.F., et al, 1997) (National Center for Biotechnology Information, 
available through http://www.ncbi.nlm.nih.gov/BLAST/). Sequence alignment and editing was 
done using VectorNTI (Invitrogen) and BioEdit (version 7.0.5.2) (Hall, T.A., 1999). 
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Phylogenetic and molecular evolutionary analyses were performed using the MEGA software, 
version 3.1 (Kumar, S., et al, 2004). Phylogenetic trees were generated using the neighbor-
joining method (Saitou, N. and Nei, M., 1987) and evolutionary distance matrices were 
calculated using the Jukes-Cantor algorithm (Jukes, T.H. and Cantor, C., 1969). 
3.3  Results and Discussion 
Five 16S rRNA gene libraries were constructed from the GEN dip solutions recovered 
at the turtle farms in June 2002, in Louisiana. Figure 3.1 shows some of the PCR products 
obtained from the amplification of cloned 16S rRNA genes. Approximately 550 clones were 
screened for the appropriate insert size of 1.5 kb; around 300 of these had the correct insert size 
and were thus selected for further identification analysis. ARDRA analysis was used as a 
guideline to select representative clones to sequence and revealed different Taq1 restriction 
digestion patterns, as illustrated in Figure 3.2.  
Sequences obtained from partial sequencing of the cloned 16S rRNA inserts lead to the 
identification of both culturable and uncultured organisms from the samples studied. Organisms 
(and accession numbers of the closest nucleotide sequence hits obtained through BLAST) 
identified by partial sequencing of the cloned 16S rRNA genes are summarized in Table 3.1. 
To perform phylogenetic and molecular evolutionary analyses, sequences were aligned 
and edited using VectorNTI (Invitrogen) and BioEdit (Hall, T.A., 1999), as described above. 
For this, a representative clone was selected from each group of identical sequences and 
designated as an operational taxonomic unit (OTU) (Table 1). Sequence data corresponding 
approximately to bases numbers 100 to 500 (E. coli numbering) (Brosius, J., et al, 1978) was 
used to generate phylogenetic trees and distance matrices as presented in Figure 3.3. In this 
study we found a more diverse group of organisms to survive GEN treatment than
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Figure. 3.1. Selection of Appropriate Clones by M13 Amplification of 
Cloned 16S rRNA Gene Inserts. Lanes 1-21 (gels A and B) show M13 PCR 
products obtained from different clones. 100 bp DNA ladder (Invitrogen) was 
used as molecular size standard (M). Clones with an appropriate size insert of 
1.5 kb were further analyzed. Clones from gel A, lanes 4, 5, 18, 19, 21, and 
gel B, lanes 2, 5, 6, 7, 17, 20, were excluded from the study due to their 
improper size.  
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Figure. 3.2: ARDRA. Lanes 2-12 & 14-23 show some of the restriction digests of the 
16S rRNA PCR products obtained using restriction enzyme Taq1. Five different 
restriction patterns are evident: A (lanes 1, 11, 16, 19), B (lanes 2, 3, 5, 6, 12), C (lanes 4, 
7, 10, 14, 15, 20-23), D (lane 8), and E (lanes 17, 18). M: DNA Molecular Weight 
Marker VIII (Roche Diagnostics) 
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Table 3.1. Organisms Identified by Partial Sequencing of 16S rRNA Genes 
 
Organism Accession % ID N1 OTU2 
Alcaligenes sp.  AJ002804 99 14 clone JVB3 
Alcaligenes xylosoxidans  AJ551119 99 10 clone JVB4 
Biocide-degrading bacterium 111  AY941083 100 10 clone JVB5 
Burkholderia sp. SE-10  AY568514 100 6 clone JVA2 
Collimonas sp. CTO 113  AY281151 99 16 clone JVB2 
Comamonas sp. JS46  AY819705 99 8 clone PPA3 
Comamonas testosteroni AY653219 99 84 clone JVA1 
Comamonas testosteroni MBIC3841 AB007997 99 10 clone PPB1 
Delftia tsuruhatensis strain ARI_5  AY684785 99 6 clone PPA4 
Flexibacter group bacterium LA48 AF513436 89 12 clone JVA6 
Methylophilus methylotrophus   AB193724 99 34 clone PPB2 
Ochrobactrum aqua-oryzae strain MTCC 
4195T. AM041247 100 2 clone JVA7 
Pseudomonas putida strain P19  AY972175 99 16 clone PPA1 
Pseudomonas sp. 48XA DQ103513 100 18 clone JVB1 
Pseudomonas sp. WT OTU2 AY965247 99 4 clone PPA2 
Uncultured bacterium clone LS27  AY559425 99 2 clone JVB6 
Uncultured bacterium clone Tc65 AF445125 95 2 clone JVA5 
Uncultured bacterium clone TM09 16S  AY838517 99 8 clone PPA5 
Uncultured bacterium DSSD57 AY328755 99 28 clone PPB3 
Uncultured beta proteobacterium clone 
ccslm36 AY133096 98 4 clone PPC1 
Uncultured Planctomycetales bacterium 
clone M10Ba43 AY360633 97 2 clone JVA4 
Xenophilus azovorans  AF285414 99 2 clone JVA3 
1 Total number of clones with indicated sequence identities. 2 Operational Taxonomic 
Units (OTUs) used to construct phylogenetic trees 
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Figure 3.3.  Phylogenetic Tree of Organisms Identified in This Study
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originally anticipated. In fact, using a culture-dependent approach we had only identified 
Alcaligenes spp. and Pseudomonas spp. of the organisms listed in Table 3.1. (Diaz, M.A., et al, 
in press). In effect, the assessment of microbial diversity is largely underestimated by classic 
culture methods (Ward, D.M., et al, 1998; Hengstmann, U., et al, 1999). In conventional 
culturing methods, specific growth conditions favor the growth of bacteria that are better 
adapted to the given culture conditions, which do not necessarily reflect the natural 
environment. Consequently, microorganisms identified by these methods do not illustrate the 
microbial community significantly (Ward, D.M., et al, 1998; Hengstmann, U., et al, 1999; 
Amann, R. and Ludwig, W., 2000). In fact, the fraction of microbial diversity which has been 
obtained from culture methods has been estimated to be less than one per cent of the total 
microbial diversity (Amann, R.I., et al, 1995; Amann, R. and Ludwig, W., 2000).  
Table 3.2 summarizes the percentages of organisms identified in each sample. All 
species found with the studies performed had been previously reported. On the other hand, 
previously reported uncultured bacteria were identified in all of the samples tested. In effect, 
these previously reported uncultured bacteria had been detected in environmental samples. 
Though it is not possible to infer an ecological role or phenotype for the organisms identified 
based on the phylogenetic position of their 16S rRNA gene sequence, the information provided 
should prove useful as a qualitative tool for the study of these bacterial communities (Ward, 
D.M., et al, 1998; Hengstmann, U., et al, 1999). Furthermore, this type of study could aid in the 
detection of possible antibiotic producers or other organisms which help maintain the antibiotic 
resistance pool and yet are missed by classical bacteriological drug-resistance testing. 
The most common genera encountered in the GEN treatment solutions were 
Comamonas spp. (34%), Pseudomonas spp. (12%), and Methylophilus spp. (11%) as can be 
seen in Table 3.2. Comamonas spp. was found in every location studied. It is important to 
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mention, though, that the culture-independent approach to the identification of bacteria in a 
community, based on 16S rRNA gene sequencing, is known to have important limitations as a 
quantitative tool (Rainey, F.A., et al, 1996; Hengstmann, U., et al, 1999). One such limitation 
is the bias obtained from the proportions of the 16S rRNA sequence types that are recovered 
(Hengstmann, U., et al, 1999). In addition, it is also not possible with the present approach to 
determine the resistance mechanisms which allow the identified non-culturable bacteria to 
survive such high levels of GEN. However, in a previous study, we found two genes which are 
carried by bacteria recovered from environmental samples with turtle farming activity, which 
exhibit high-level GEN resistance (Diaz, M.A., et al, in press). These are aac(3)IIa and 
aac(3)VIa, which code for aminoglycoside acetyl-transferase enzymes. Only gene aac(3)IIa 
was detected in pseudomonads and other non-fermentor Gram-negative bacilli in the studies 
performed (Diaz, M.A., et al, in press). We do not discard the possibility of the dissemination 
of these genes amongst some of the organisms detected in this study. Other resistance 
mechanisms often observed in the identified bacteria include adaptive resistance and reduced 
uptake of the antibiotic (Karlowsky, J.A., et al, 1996; Putman, M., et al, 2000). In addition, 
recent studies performed elsewhere have reported plasmid-mediated genes which confer high-
level aminoglycoside resistance in Klebsiella pneumoniae (Galimand, M., et al, 2003), 
Pseudomonas aeruginosa (Yokoyama, K., et al, 2003) Serratia marcescens (Doi, Y., et al, 
2004) and other microorganisms (Yamane, K., et al, 2005). Further studies would be needed to 
determine the resistance mechanisms which allow these bacteria to survive such high-levels of 
GEN.  
In this study, we used a culture-independent approach for the identification of bacteria 
that can survive or thrive in GEN treatment solutions as it provides a less biased technique for 
Table 3.2. Most Prevalent Genera Identified by Partial Sequencing of 16S rRNA Genes in GEN 
                  Treatment Solutions From Five Different Locations in Louisiana in June, 2002. 
 
 Sample Site  
Organism JVA JVB PPA PPB PPC Total 
 (n=60) (n=76) (n=56) (n=76) (n=30) % (N) 
Comamonas spp. 63.3 (38) 7.9 (6) 39.3 (22) 13.2 (10) 86.7 (26) 34 (102) 
Pseudomonas spp.  23.7 (18) 35.7 (20)   13 (38) 
Methylophilus spp.      44.7 (34)  11 (34) 
Alcaligenes spp.   31.6 (24)    8 (24) 
Collimonas spp.   21.1 (16)    5 (16) 
Flexibacter spp. 20.0 (12)     4 (12) 
other 10.0 (6) 13.2 (10) 10.7 (6) 5.3 (4)  9 (26) 
Uncultured bacteria clones 6.7 (4) 2.6 (2) 14.3 (8) 36.8 (28) 13.3 (4) 15 (46) 
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the qualitative study of bacterial communities (Ward, D.M., et al, 1998; Hengstmann, U., et al, 
1999; Amann, R. and Ludwig, W., 2000; Heuer, H., et al, 2002). With this approach, we 
identified bacteria that are able to survive high concentrations of GEN (1000 µg/ml) for one 
year at 4oC, which are the conditions at which the antibiotic baths are stored, and may possibly 
serve as antibiotic resistance reservoirs but yet would escape detection by classic antibiotic 
resistance monitoring.  
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CHAPTER 4: 
INTEGRONS AND GENE CASSETTES IN BACTERIA FROM 
THE TURTLE FARM ENVIRONMENT 
 94
4.1  Introduction 
Gentamicin is an antibiotic which belongs to the family of the aminoglycosides, which 
are broad-spectrum antibiotics commonly used in combination with β-lactams for the treatment 
of aerobic Gram-negative infections (Miller, G.H., et al, 1997; Vakulenko, S.B. and 
Mobashery, S., 2003). In recent studies, bacteria which were highly resistant to gentamicin 
were recovered from various sources on commercial turtle farms in Louisiana (D'Aoust, J.Y., et 
al, 1990; Diaz, M.A., et al, 2000). This lead to investigation into resistance determinants as 
well as the molecular environment of the resistance genes identified (Diaz, M.A., et al, 2001; 
Diaz, M.A., et al, 2002b; Diaz, M.A., et al, 2002a). Plasmid-encoded aminoglycoside 
acetyltransferase genes aac(3)IIa and aac(3)VIa were found to be the most prevalent in 
gentamicin resistant bacteria recovered from turtle farms (Diaz, M.A., et al, 2000; Diaz, M.A., 
et al, in press). Furthermore, the gene aac(3)VIa was found within a class 1 integron (Stokes, 
H.W. and Hall, R.M., 1989; Diaz, M.A., et al, 2001; Diaz, M.A., et al, 2002b).   
Integrons, which were first described by Stokes and Hall in 1989, are gene-capture 
molecular elements that contain an integrase gene, intI, and an arrangement of gene cassettes 
which are expressed from a common promoter, Pant (Stokes, H.W. and Hall, R.M., 1989; Collis, 
C.M., et al, 1998; Ploy, M.C., et al, 2000). These molecular elements have since been detected 
on plasmids and in the chromosomes of Gram-negative bacteria (Hall, R.M. and Stokes, H.W., 
1993; Fluit, A.C. and Schmitz, F.J., 1999). Class-1 integrons, the most prevalent among clinical 
isolates (Fluit, A.C. and Schmitz, F.J., 1999; White, P.A., et al, 2001; Fluit, A.C. and Schmitz, 
F.J., 2004), are characterized by two conserved regions (5’-CS and 3’-CS) flanking a variable 
region (Hall, R.M. and Collis, C.M., 1995). The 5' conserved region includes the integrase gene 
intI1 and a gene cassette attachment site, attI (Collis, C.M., et al, 1993; Hall, R.M. and Collis, 
C.M., 1995; Partridge, S.R., et al, 2000). The 3' conserved region is characterized by the 
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presence of a quaternary ammonium compound resistance gene, qacE∆1, a sulfonamide 
resistance gene, sul1, and two open reading frames with unknown functions: orf5 and orf6 
(Stokes, H.W. and Hall, R.M., 1989; Hall, R.M., et al, 1994). The variable region of class-1 
integrons can include one or more gene cassettes (Stokes, H.W. and Hall, R.M., 1989; Hall, 
R.M. and Stokes, H.W., 1993).  
The majority of gene cassettes described to date code for antibiotic resistance (Fluit, 
A.C. and Schmitz, F.J., 1999; Fluit, A.C. and Schmitz, F.J., 2004) and are thus known as 
multiple resistance integrons, or MRIs (Recchia, G.D. and Hall, R.M., 1995; Fluit, A.C. and 
Schmitz, F.J., 1999; Mazel, D. and Davies, J., 1999). There is a larger type of integron, referred 
to as “super-integrons”, or SIs, which was originally described in Vibrio cholerae (Mazel, D., 
et al, 1998; Rowe-Magnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D., 1999; Clark, 
C.A., et al, 2000). SIs have later been found as components of the genomes of many γ-
proteobacteria, such as Xanthomonas spp., Shewanella spp. and Pseudomonas spp. (Rowe-
Magnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D., 1999; Vaisvila, R., et al, 2001).  
In order to provide Salmonella-free pet turtles to the export market, the Louisiana pet 
turtle industry treats turtle eggs with gentamicin sulfate (Garasol; Shering Corp., Bloomfield, 
N.J.) at 1000 ppm (µg/ml) (Siebeling, R.J., et al, 1975; Michael-Marler, S., et al, 1983; 
Siebeling, R.J., et al, 1984), using a pressure-differential gentamicin egg-dip procedure adapted 
from the turkey industry (Saif, Y.M. and Shelly, S.M., 1973; Greenfield, J., et al, 1975; 
Ekperigin, H.E., et al, 1983). In previous studies, we detected gene aac(3)VIa as a gene cassette 
in gentamicin resistant isolates from turtle farms as well as some integron-associated elements 
in isolates carrying aac(3)IIa (Diaz, M.A., et al, 2000; Galimand, M., et al, 2003; Galimand, 
M., et al, 2005; Diaz, M.A., et al, in press).  
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The goal of the present study was to characterize the class-1 integrons in gentamicin 
resistant isolates recovered from pet turtle farms and to investigate any genes which may be co-
selected in the presence of gentamicin. 
4.2  Materials and Methods 
4.2.1. Bacterial Strains and Plasmids Used in This Study 
Bacterial strains used in this study were isolated previously (Diaz, M.A., et al, in press) 
from environmental samples with turtle farming activity and are summarized in Table 4.1. 
Gram-negative bacteria were routinely grown at 37oC using McConkey (Difco, Detroit, MI) 
plates. Laboratory strains were grown using Luria-Bertani (LB) media (Sambrook, J., et al, 
1989). All GEN-resistant strains were propagated in media supplemented with 100 µg/ml GEN. 
A summary of all laboratory bacterial strains and plasmids used in this study is found in Table 
4.1. 
4.2.2. Antibiotic Susceptibility Assays 
The Kirby-Bauer disk-diffusion assay was done using MH agar plates according to 
NCCLS standards (NCCLS, 1999) using the following antibiotics: GEN (10 µg), KAN (30 µg), 
TOB (10 µg), AMK (30 µg), ampicillin (AMP) (10 µg), tetracycline (TET) (30 µg), 
chloramphenicol (CHL) (30 µg), polymixin B (PMB) (300 units), cephalothin (CEF) (30 µg), 
cefotaxime (CTX) (30 µg), trimethoprim (TMP) (5 µg), and nitrofurantoin (NIT) (300 µg) 
(Difco). Inhibition zone breakpoints were interpreted according to information supplied by the 
manufacturer and to NCCLS standards (NCCLS, 1999).  
4.2.3. Screening for Genes Associated with Class-1 Integrons by PCR 
In order to screen for the presence of putative integrases and gene cassettes which could 
contribute to the spread and increased level of gentamicin resistance, we screened for putative  
 Table 4.1.  Bacterial Strains and Plasmids Used in This Study 
Strain or plasmid Relevant characteristics Source or Reference 
Bacterial strains   
E. coli TOP10 Electrocompetent or chemically competent.  
F- mcrA ∆(mrr-hsdRMS-mcrBC) 
Ф80lacZ∆M15 ∆lacX74 recA1 deoR araD139 
(ara-leu)7697 galU galK rpsL  
(Strr) endA1 nupG GENs (MIC: <3.9 µg/ml) 
Invitrogen 
   
Pseudomonas aeruginosa 
strain PS7 
GEN MIC: >2000 µg/ml (12) 
Stenotrophomonas maltophilia 
strain St16 
GEN MIC: >2000 µg/ml (12) 
Salmonella enterica subsp. 
enterica strain S5 
GEN KAN TOB; GEN MIC: >2000 µg/ml (12) 
Salmonella enterica subsp. 
arizonae strain PH5 
GEN KAN TOB; GEN MIC: >2000 µg/ml (12) 
Enterobacter cloacae strain E19 GEN KAN TOB; GEN MIC: >2000 µg/ml (12) 
Citrobacter freundii strain C14 GEN KAN TOB; GEN MIC: >2000 µg/ml (12) 
   
  
(table cont’d) 
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Plasmids   
pCR2.1-TOPO cloning and sequencing vector; KAN Invitrogen 
pCSt16 pCR2.1-TOPO derivative with 1 kb insert from 
5’CS-3’CS PCR obtained from 
Stenotrophomonas maltophilia strain St16 
this study 
pCSeS5 pCR2.1-TOPO derivative with 1 kb insert from 
5’CS-3’CS PCR obtained from Salmonella 
enterica subsp. enterica strain S5 
this study 
pCSaPH5 pCR2.1-TOPO derivative with 1 kb insert from 
5’CS-3’CS PCR obtained from Salmonella 
enterica subsp. arizonae strain PH5 
this study 
pCEcE19 pCR2.1-TOPO derivative with 1 kb insert from 
5’CS-3’CS PCR obtained from Enterobacter 
cloacae strain E19 
this study 
pCCfC14 pCR2.1-TOPO derivative with 1 kb insert from 
5’CS-3’CS PCR obtained from Citrobacter 
freundii strain C14 
this study 
pCPaPs7 pCR2.1-TOPO derivative with 2.5 kb insert 
from 5’CS-3’CS PCR obtained from 
Pseudomonas aeruginosa strain Ps7 
this study 
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integrase genes and gene cassettes in the turtle pond environment using degenerate primers 
previously published (Nield, B.S., et al, 2001; Stokes, H.W., et al, 2001). Degenerate primers 
used to detect these putative genes and PCR conditions are summarized in Table 4.2. Different 
size PCR products were purified from agarose gels using QIAquick Spin kits (Qiagen, 
Valencia, CA) and cloned using Invitrogen’s TOPO-TA cloning kit (Invitrogen, Carlsbad, CA), 
as recommended by the manufacturer. Recombinant plasmids were transformed into 
chemically competent TOP10 Escherichia coli cells (Invitrogen), and transformants were 
selected on LB-KAN plates (50 µg/ml). DNA inserts from these clones were amplified using 
the M13 universal primers.  
In addition, PCR assays were designed to screen environmental isolates for genes 
commonly associated with class 1 integrons, using primers published elsewhere (Levesque, C., 
et al, 1995; Schwocho, L.R., et al, 1995; Sandvang, D., et al, 1997; Galimand, M., et al, 2003) 
and summarized in Table 4.2. PCR screening of genes intI, sul1 (Stokes, H.W. and Hall, R.M., 
1989; Schwocho, L.R., et al, 1995), and of armA, reported to confer high-level aminoglycoside 
resistance in Gram-negative bacteria and to be associated with complex class-1 integrons 
(Galimand, M., et al, 2003; Galimand, M., et al, 2005), was done in separate reactions. PCR 
assays were also performed to detect complex integron-associated orf513, coding a putative 
recombinase. Other primer sets used to amplify these integron regions include: 1) 5'CS and 
3'CS; 2) 5'CS and orf513-R and 3) orf513-F and sulR. 
To prepare DNA for PCR, pelleted cells from 1 ml of overnight cultures were 
resuspended in 100 µl dH2O and lysed through two 5 min. freeze-boil cycles. Two µl of the 
supernatants were used as templates in 50 µl PCR reactions. PCR was done using the 
FailSafe™ PCR System, buffer “G”, or buffer “F” (Epicentre Biotechnologies, Madison, WI), 
Table 4.2.  Primers Used for PCR and Sequencing 
PCR target  Primer Amplicon size (bp) Sequence (5' → 3') 
Accession No. 
(Reference) 
intI1 intIF 845 CTA CCT CTC ACT AGT GAG GGG CGG X15852 (44, 47) 
 intIR  GGG CAG CAG CGA AGT CGA GGC  
intI1 int1F 568 ACA TGT GAT GGC GAC GCA CGA M95287 (17, 47) 
 int1R  ATT TCT GTC CTG GCT GGC GA  
intI1, intI2, intI3 hep35 491 TGC GGG TYA ARG ATB TKG ATT T (54) 
 hep36  CAR CAC ATG CGT RTA RAT  
cassette array hep74 variable CGG GAT CCC GGA CGG CAT GCA CGA TTT GTA (54) 
 hep51  GAT GCC ATC GCA AGT ACG AG  
intIN / array HS286 variable GGG ATC CTC SGC TKG ARC GAM TTG TTA GVC (30, 48) 
 HS287  GGG ATC CGC SGC TKA NCT CVR RCG TTA GSC  
 HS298  TGG ATC CCA CRT GNG TRT ADA TCA TNG T  
cassette array 5’CS variable GGC ATC CAA GCA GCA AGC M73819 (24) 
 3’CS  AAG CAG ACT TGA CCT GAT  
orf513 orf513F  CTC GCT ACA TCC AAC AAG AA (31) 
 orf513R  TGT CAC GCC AGT TAG TAT CG  
aac(3)II aac3F 860 ATG CAT ACG CGG AAG GCA AT L22613 (17) 
 aac3R  CTA ACC TGA AGG CTC GCA A  
aac(3)-IIa aacIIaF 900 GGG AAT TCA GAG GAG ATA TCG CGA TGC ATA CG X13543 (12) 
 aacIIaR  CAT TGT CGA CGG CCT CTA ACC  
aac(3)-VIa aacVIaF 465 CGC TCA GGC GAT ATG GTG AT L22613 (12) 
 aacVIaR  CAT AAT GGA GCG CGG TGA CT  
sul1 sulF1 840 ATG GTG ACG GTG TTC GGC AT U12441 (17, 47) 
 sulR  CTA GGC ATG ATC TAA CCC TC  
 M13F (-20) variable GTA AAA CGA CGG CCA G (Invitrogen) 
 M13R  CAG GAA ACA GCT ATG AC   
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according to instructions provided by the manufacturer. Thermocycler conditions were set as 
follows: [1X (96oC, 5 min); 35X (96oC, 30 sec; 55oC, 30 sec; 70oC, 60 sec); (70oC, 7 min)]. 
PCR products were visualized by agarose gel electrophoresis using 2% Agarose I in 0.5x TBE 
buffer and staining with ethidium bromide. Some of the PCR products obtained were 
sequenced in order to confirm amplification of the appropriate genes and to compare with 
published sequences in the databases. For this, PCR products were purified using QIAquick 
Spin columns (Qiagen) and ligated into pCR2.1-TOPO using the TOPO-TA cloning kit 
(Invitrogen), as indicated by the manufacturer. Sequencing of appropriate clones was done 
using the internal vector sequencing primers, as described above.  
4.2.4. Sequencing and Computer Analysis 
Sequencing was done using the M13 universal primers with fluorescent dye-labeled 
dideoxynucleotides with an ABI Prism 310 Genetic Analyzer (Applied Biosystems, Foster 
City, CA). Sequence analysis was done using VectorNTI (Invitrogen), BLAST (2) and 
GeneBank (National Center for Biotechnology Information, available through 
http://www.ncbi.nlm.nih.gov/BLAST/). 
4.3  Results 
The goal of this study was to search for integron classes carrying gentamicin resistance 
genes which could also contribute to the co-selection of other resistance genes under 
gentamicin selective pressure. PCR amplification of gene intI1 using primers intIF and intIR 
(Schwocho, L.R., et al, 1995) allowed the detection of class 1 integrase in E. coli-pAriPH5, E. 
coli-pEntE19, but not in Pseudomonas aeruginosa, Stenotrophomonas maltophilia, or E. coli-
pSalS5 (Figure 4.1). Since aac(3)IIa was encoded in the latter organisms, and this gene was 
reported to be associated with gene armA, as well as orf513, and intI1 (Galimand, M., et al, 
2003; Galimand, M., et al, 2005), these genes were screened for with the primers published by  
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 M       1      2      3       4 
bp 
2072 
1500 
intI1 
600 
100 
 
Figure 4.1.  PCR Amplification Products of intI1 Gene. 
PCR reaction was carried out using intIF and intIR primers. 
Lane 1, Ps. aeruginosa; lane 2, E. coli-pSalS5; lane 3, E. coli-
pAriPH5; lane 4, E. coli-pEntE1; lane M, 100 bp molecular 
size marker. 
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these researchers (Galimand, M., et al, 2003; Partridge, S.R. and Hall, R.M., 2003). Gene armA 
was not detected in any of the isolates assayed in this study (Chapter 2). In addition, screening 
for complex-integron associated orf513 has not been detected in the isolates tested thus far. 
However, when screening for integrase class 1 with this primer set, it was possible to detect 
intI1 in isolates carrying aac(3)IIa, as well as those carrying aac(3)VIa. Figure 4.2 summarizes 
these findings. 
Primers hep35 and hep36 anneal to conserved regions of integrase genes intI1, intI2, 
and intI3 (White, P.A., et al, 2001). Primers hep74 and hep51 were designed to amplify class 2 
integron cassette regions by annealing to attI2 and to orfX, which is downstream of the cassette 
region within Tn7 (White, P.A., et al, 2001). Moreover, primers HS286, HS287 and HS298 
have been used to detect integrase genes and cassettes from environmental DNA with success 
(Nield, B.S., et al, 2001; Stokes, H.W., et al, 2001). Numerous amplicons with appropriate 
sizes (greater than 1 kb) were obtained from over 200 isolates tested, and cloned into pCR2.1-
TOPO using the TOPO-TA cloning kit, but sequencing of these clones did not lead to the 
detection of integrase genes other than intI1. 
PCR performed using primer set 5’CS and 3’CS (Levesque, C., et al, 1995) produced 
amplicons with sizes which could include gene cassettes. Interestingly, different sizes of 
amplicons were obtained from isolates which are known to carry the same gene (Figure 4.3). 
Preliminary sequencing has confirmed that these are in fact integron elements, or cassettes 
(data not shown). Sequencing of these clones is currently underway.  
4.4  Discussion 
The goal of the present study was to characterize the integrons in gentamicin resistant 
isolates recovered from the pet turtle farm environment, since these molecular elements can 
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Figure 4.2.  PCR Amplification Products of Integron-Associated 
Genes intI1, aac(3)IIa, and aac(3)VIa. Lanes 1 and 5, amplification 
of aac(3)II using primers aacIIF and aacIIR (Galimand, M., et al, 
2003); lanes 2 and 6, multiplex PCR amplification of genes aac(3)IIa 
and aac(3)VIa using primers aacIIaF, aacIIaR, aacVIaF and aacVIaR 
(Vliegenthart, J.S., et al, 1990; E.C. Achberger, personal 
communication); lanes 3 and 7, amplification of intI1 using primers 
int1F and int1R (Galimand, M., et al, 2003); lanes 4 and 8, 
amplification of intI1 using primers intIF and intIR (Schwocho, L.R., 
et al, 1995); lanes M, 100 bp molecular size marker.    
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Figure 4.3.  PCR Amplification Products of 5’CS-
3’CS Primers. Lane 1, Pseudomonas aeruginosa strain 
Ps7; lane 2, Stenotrophomonas maltophilia strain St16; 
lane 3, Salmonella enterica subsp. enterica strain S5; 
lane 4, Salmonella enterica subsp. arizonae strain PH5; 
lane 5, Enterobacter cloacae strain E19; lane 6, 
Citrobacter freundii strain C14. 
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contribute not only to the spread of gentamicin resistance but also to that of other resistance 
genes of public health importance, which may be co-selected in the presence of gentamicin. 
Four different classes of integrons had been identified before 2001, encoding different 
integrase genes and overall gene arrangements; these were integrons class-1 (Stokes, H.W. and 
Hall, R.M., 1989), class-2, class-3 (Collis, C.M., et al, 2002) and class-4 (Mazel, D., et al, 
1998). In a previous study, we had detected the presence of the gene aac(3)VIa associated with 
the integron class-1 integrase gene. However, isolates carrying aac(3)IIa had been considered 
intI1- negative when assayed with the primer set described (Schwocho, L.R., et al, 1995; Diaz, 
M.A., et al, in press), which was consistent with reports at the time (Brau, B., et al, 1984; 
Allmansberger, R., et al, 1985; Rather, P.N., et al, 1992; Rather, P.N., et al, 1993; Diaz, M.A., 
et al, 2000; Diaz, M.A., et al, 2001). On the other hand, we had detected the presence of 
aac(3)IIa in different plasmids and diverse bacterial genera of organism, so we hypothesized 
that the gene was encoded within a mobile molecular element, such as another integron besides 
class-1, possibly a superintegron as described in Xanthomonas spp., Shewanella spp., and 
Pseudomonas spp. (Rowe-Magnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D., 
1999; Vaisvila, R., et al, 2001). For this reason we screened for the presence of putative 
integrase (Nield, B.S., et al, 2001) and gene cassette genes (Stokes, H.W., et al, 2001), using 
degenerate primers designed elsewhere to detect these elements from environmental DNA. 
None of the PCR amplicons obtained with these primers rendered any gene which could be 
associated to an integron element, other than the ones already identified (Diaz, M.A., et al, 
2002b; Diaz, M.A., et al, 2002a).  
Preliminary sequencing of the different integron molecular environments in this study 
did not lead to the detection of any mutation which could have an effect on the expression of 
the gentamicin resistance gene cassettes. Gene aac(3)VIa was found to be in the first position in 
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the gene cassette array, near the integrase gene. On the other hand, even though we did not 
detect intI1 gene associated with the gene aac(3)IIa in our preliminary work, we did detect 
other integron elements in bacteria carrying this gene (Diaz, M.A., et al, 2002b; Diaz, M.A., et 
al, 2002a). Interestingly, recent studies have also depicted the aac(3)IIa gene to be surrounded 
by integron elements (Galimand, M., et al, 2003; Galimand, M., et al, 2005). In fact, the 
molecular environment of the armA gene has been depicted as a composite integron 
environment, characterized by the presence of a 5’-CS and a 3’-CS interspanning a variable 
region which includes a sul1 gene and a gene known as orf513 (Partridge, S.R. and Hall, R.M., 
2003; Galimand, M., et al, 2005). This same type of arrangement has later been described in 
other organisms and it is thought to involve a mobile integrative structure known as a 
conjugative transposon (Salyers, A.A., et al, 1995; Partridge, S.R. and Hall, R.M., 2003). The 
latter are DNA elements that can excise themselves to form a covalently closed circular 
intermediate (Salyers, A.A., et al, 1995); this intermediate can reintegrate itself within the same 
organism or, it can be transfered by conjugation to a recipient cell and then integrate in the 
recipient’s genome (Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002; Partridge, S.R. and 
Hall, R.M., 2003). These integrative molecular elements were first found in Gram-positive 
bacteria such as the streptococci and enterococci (Tolmasky, M.E., 2000) and were barely 
mentioned before 1996 in connection with Gram-negative bacteria (Pembroke, J.T., et al, 
2002). Conjugative transposon-like elements have later been detected in Gram-negative 
bacteria such as Bacteroides spp. (Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002) and 
though characterized in a lesser extent, in the Enterobacteriaceae. They have been reported in 
Salmonella spp., Proteus spp., in the R391 element and in the SXT element in Vibrio spp. 
(Salyers, A.A., et al, 1995; Beaber, J.W., et al, 2002; Pembroke, J.T., et al, 2002; Partridge, 
S.R. and Hall, R.M., 2003).  
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The variable region of class-1 integrons can code for one or more gene cassettes 
(Stokes, H.W. and Hall, R.M., 1989; Hall, R.M. and Stokes, H.W., 1993). In this study, we 
used published conserved sequence primers (Levesque, C., et al, 1995; Sandvang, D., et al, 
1997) to screen for the presence of different gene arrays in the isolates under study. 
Interestingly, this not only lead to the detection of the expected gene cassette amplicons from 
organisms known to be carrying gene aac(3)VIa within a class-1 integron, but we also obtained 
amplicons for organisms which carried gene aac(3)IIa and which were recently detected to 
carry intI1. Therefore, it is possible that gene aac(3)IIa is carried by a complex integron and 
thus was not detected as such with the primer pair used to detect the classic structure of 
integron class-1 (Galimand, M., et al, 2003). Sequencing of amplicons obtained with 5’CS-
3’CS primers will shed light in this regard (Levesque, C., et al, 1995; Sunde, M. and Sorum, 
H., 1999). Transfer of aac(3)IIa may involve a complex integron class-1. The presence of 
aac(3)IIa and aac(3)VIa in mobile molecular elements explains the distribution of these genes 
in the different bacterial genera described in this study (Holmes, A.J., et al, 2003). Further 
studies of their molecular environment are required in order to detect and characterize these 
mobile molecular elements, and to detect genes which may be co-selected in the presence of 
gentamicin. 
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Salmonella enterica subsp. enterica serovar Enteritidis is the major cause of Salmonella 
spp. food poisoning in the U.S., since it is a frequent contaminant of chicken eggs (Cohen, 
M.L., et al, 1980; Carattoli, A., 2003). S. enterica subsp. arizonae commonly inhabits the 
cloacae of reptiles without causing disease in these animals (Siebeling, R.J., et al, 1975a; 
Siebeling, R.J., et al, 1984; Ebani, V.V., et al, 2005). Turtle farming has been an important 
economic activity in the state of Louisiana since the 1930s, contributing approximately 30 
million dollars to the State’s economy (Siebeling, R.J., et al, 1975b). The tracing of several 
salmonellosis outbreaks to pet turtles in the 1970s lead to a domestic ban on the sale of small 
carapace turtles in 1975 by the FDA (Siebeling, R.J., et al, 1975a; Cohen, M.L., et al, 1980; 
Shane, S.M., et al, 1990). The estimated 300,000 cases of human salmonellosis that could be 
traced to pet turtles (Siebeling, R.J., et al, 1975a; Cohen, M.L., et al, 1980), reportedly 
accounted for an approximate 14% of Salmonella spp. infections per year (Cohen, M.L., et al, 
1980). The domestic ban on the sale of baby turtles did not affect the export market 
significantly, which continued to prosper, with 12 million hatchlings being exported from 
Louisiana to Western Europe, South America, and Asia every year, accounting for about 90% 
of the pet turtle world market (Michael-Marler, S., et al, 1983; Siebeling, R.J., et al, 1984; 
Izadjoo, M.J., et al, 1987). However, to guarantee a safe pet for the market, turtle export is 
subject to prior testing and certifying hatchlings as Salmonella-spp.-free by independent FDA-
approved laboratories, which perform routine bacteriological and molecular assays such as 
PCR, before certifying hatchlings for export (Siebeling, R.J., et al, 1984). 
Antibiotic use constitutes a selective pressure that favors the growth of bacterial strains 
which are resistant, or have acquired resistance, to the particular antibiotic (Davies, J. and 
Smith, D.I., 1978; Levy, S.B., 1998; Mazel, D. and Davies, J., 1999; Levy, S.B., 2002). Thus, 
the development of gentamicin resistance has been of concern in the agricultural setting, 
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particularly in the turkey farm industry, where this antibiotic has been used to eradicate 
Salmonella spp. from turkey eggs (Ekperigin, H.E., et al, 1983; Hirsh, D.C., et al, 1983). The 
concern of the emergence of gentamicin-resistant Salmonella spp. has also been voiced for pet 
turtles being exported from Louisiana to other countries (D'Aoust, J.Y., et al, 1990). This study 
constitutes a report of the molecular causes of the gentamicin resistance problematic in the 
turtle farms.  
Bacteria that were identified by standard bacteriological assays from the samples taken 
at the turtle farms include organisms such as Salmonella enterica subsp. enterica, Salmonella 
enterica subsp. arizonae, Enterobacter cloacae, Citrobacter freundii, Stenotrophomonas 
maltophilia and Pseudomonas aeruginosa, among others (Chapter 2). These organisms were 
found to express high-level resistance to gentamicin. This is of particular concern given that 
aminoglycosides are reportedly antibiotics of choice for the treatment of infections from Gram-
negative bacteria such as Escherichia coli, Salmonella spp., Shigella spp., Enterobacter spp., 
Citrobacter spp., Acinetobacter spp., Proteus spp., Klebsiella spp., Serratia spp., Morganella 
spp., and Pseudomonas spp. (Vakulenko, S.B. and Mobashery, S., 2003).  
Bacteria can acquire antibiotic resistance genes from other organisms through 
conjugation, transformation and transduction (Mazel, D. and Davies, J., 1999). Moreover, 
mobile genetic elements such as transposons, integrons, Gram-positive conjugative transposons 
and Gram-negative conjugative transposons, allow bacteria to acquire new genes through 
intermolecular genetic exchange (Davies, J. and Smith, D.I., 1978; Stokes, H.W., et al, 2001; 
Pembroke, J.T., et al, 2002; Carattoli, A., 2003; Partridge, S.R. and Hall, R.M., 2003). These 
mobile DNA elements have played an important role in the evolution of microorganisms 
(Recchia, G.D. and Hall, R.M., 1997; Simjee, S. and Gill, M.J., 1997; Hall, R.M., et al, 1999; 
Tolmasky, M.E., 2000; Pembroke, J.T., et al, 2002; Rowe-Magnus, A.D., et al, 2002). In this 
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study, the majority of the organisms tested for plasmids showed the presence of one or more 
plasmids. Some of these plasmids were shown to be conjugative plasmids, as determined by 
bacterial mating experiments (Chapter 2) in which plasmids were transfered from 
environmental isolates to a laboratory AZI resistant E. coli strain BM14. Transconjugant 
organisms were not obtained from all environmental donor strains assayed, as is summarized in 
Table 5.1. It is possible that no transconjugants were obtained for donor strains such as 
Pseudomonas spp., Stenetrophomonas spp., and Acinetobacter spp., and other non-fermenting 
organisms, since they are more distant phylogenetically to the recipient E. coli strain used in 
these experiments, than the organisms for which mating experiments were successful, namely, 
Salmonella spp., Enterobacter spp., and Citrobacter spp. Consequently, numerous barriers for 
conjugation could have taken effect in the former. A scheme illustrating the assays performed 
for the transfer of GEN resistance is depicted in Figure 5.1. From these experiments it was 
evidenced that the conjugative R-plasmids isolated from all transconjugants and transformants 
obtained in this study have relatively large sizes, ranging from ca. 45 to 145 kbp, as can be seen 
in Figure 5.2.  
Microorganisms can be intrinsically resistant to an antibiotic, or become resistant to the 
drug through mutations of the antibiotic target site, or by the acquisition of new resistance 
genes (Levy, S.B., 1998; Mazel, D. and Davies, J., 1999; Rowe-Magnus, D.A. and Mazel, D., 
1999). Bacteria can become resistant to antibiotics through a variety of mechanisms, which 
include the modification of the antibiotic target, reduced accumulation of the drug within the 
cell, and the enzymatic modification of the antibiotic molecule (Davis, B.D., 1987; Levy, S.B., 
1998; Mazel, D. and Davies, J., 1999). The two main modes through which bacteria can 
become resistant to aminoglycosides by modifications of the ribosome are through mutations in 
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Table 5.1.  Conjugative Transfer of GEN Resistance Genes 
 
Donor Recipient GmR AziR Transconjugants 
Pseudomonas aeruginosa  - 
Stenotrophomonas maltophilia  - 
Acinetobacter baumanii    - 
Proteus vulgaris  - 
Providencia stuartii E. coli BM14 AziR - 
Salmonella. enterica subsp. enterica  + 
Salmonella enterica subsp. arizonae  + 
Enterobacter cloacae  + 
Citrobacter freundii  + 
 
 
conjugation transformation 
Environmental donor E. coli BM14 recipient E. coli TOP10 recipient 
Sal. enterica    
subsp. arizonae  
Figure 5.1. Diagram of Transfer of GEN resistance 
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  M          1           2          3           4           5 
145 kb 
115 kb 
45 kb 
 
Figure 5.2. PFGE of R-plasmids isolated from transconjugants 
obtained after conjugation with Salmonella enterica subsp. 
enterica serovar Enteritidis, Salmonella enterica subsp. arizonae 
strains PH5 and A40, Enterobacter cloacae and Citrobacter 
freindii. Lane M, PFG molecular size marker; lane 1, plasmid 
pSalS5; lane 2, plasmid pAriPH5; lane 3, plasmid pAriA40; lane 
4, plasmid pEnt19; lane 5, plasmid pCit14. 
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ribosomal proteins or the rRNA and by the enzymatic modification of the ribosome (Davis, 
B.D., 1987; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, S., 2003). Any 
mutation that affects the binding sites of the ribosome can reduce the binding affinity of the 
drug to the ribosome and lead to varied levels of resistance. The effects of such mutations 
depend on the nature of the mutation and on the chemistry of the drug (Fourmy, D., et al, 1996; 
Carter, A.P., et al, 2000; Llano-Sotelo, B., et al, 2002). Nevertheless, it is unlikely that the 
organisms investigated in the present study expressed such high-levels of resistance to 
gentamicin due to mutations in the target site, the ribosome, since these levels of resistance 
were transferable by conjugation in at least some organisms, such as Salmonella spp., 
Enterobacter spp., and Citrobacter spp., as shown in Chapter 2.  
The other mode of target site alteration leading to aminoglycoside resistance is through 
the enzymatic modification of the ribosome (Davis, B.D., 1987; Cundliffe, E., 1989; Wright, 
G.D., et al, 1998). This is a common mechanism used by aminoglycoside producers to protect 
themselves from the antibiotics they produce (Cundliffe, E., 1989; Yoshizawa, S., et al, 1998). 
Aminoglycoside resistance by enzymatic modification of the ribosome has recently been 
detected in bacteria other than antibiotic producers (Galimand, M., et al, 2003; Yokoyama, K., 
et al, 2003; Doi, Y., et al, 2004; Yamane, K., et al, 2004). Usually the activities of most 
aminoglycoside modifying enzymes result in effective resistance to aminoglycoside antibiotics, 
but only a few phosphotransferase enzymes have been reported to produce high-levels of 
resistance to these antibiotics, namely the bifunctional enzyme aph(2”)-aac(6’) (Ferretti, J.J., et 
al, 1986), and phosphotransferases aph(2”)Ib, aph(2”)Ic and aph(2”)Id (Galimand, M., et al, 
2003; Vakulenko, S.B. and Mobashery, S., 2003). Table 5.2 summarizes the main features of 
these enzymes, which confer the HLGR phenotype in Gram-positive organisms. Table 5.3, 
  
 
 
 
Table 5.2.  Aminoglycoside Modifying Enzymes Confering HLGR  
 
Gene Characteristics  Identified in  Reference 
aph(2”)-aac(6’) - HLGR 
- Tn4001 
- IS256 
Staph. aureus  
streptococci  
enterococci  
Ferretti et al (1986) 
aph(2”)-Ib 
             -Ic 
            -Id 
- HLGR 
- plasmid-encoded 
Ent. faecium  
enterococci 
Kao et al (2000) 
Chow et al (1997) 
Tsai et al (1998) 
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Table 5.3.  Ribosomal Methyltransferase Enzymes Confering HLAR  
 
Gene Characteristics  Identified in  Reference 
armA - HLAR 
- plasmid-encoded 
- 37-47% similarity AG 
producers 
- low GC content   
- aac3-II dhfrXII, sul1, 
ant3"9,  blaTEM1  and 
blaCTX-M 
Klebsiella pneumoniae  
clinical strain 
Galimand et al (2003) 
rmtA - HLAR 
- plasmid-encoded 
- MIC>1024 mg/L 
- 55% GC content 
- Tn5041 
Pseudomonas aeruginosa 
clinical strain 
Yokoyama et al (2003)      
rmtB - HLAR 
- 82% identity with RmtA 
- plasmid-encoded 
Serratia marcescens  
clinical strain 
Doi et al  (2004)  
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on the other hand, summarizes the characteristics of genes conferring the HLAR phenotype in 
Gram-negative organisms.  
To the best of our knowledge, there had been no reports in the literature of high-level 
resistance to gentamicin in Gram-negative bacteria before this study was started in 1999 (Diaz, 
M.A., et al, 2000; Diaz, M.A., et al, in press). On the other hand, there had been an abundance 
of reports on high-level gentamicin resistance for Gram-positive bacteria (Chow, J.W., 2000). 
To be effective, aminoglycosides must first penetrate the cell wall and membranes and 
reach their target, the bacterial ribosome (Bryan, L.E. and Van Den Elzen, H.M., 1977; Martin, 
N.L. and Beveridge, T.J., 1986; Davis, B.D., 1987). Some microorganisms can inhibit this 
important step of the aminoglycoside mode of action, particularly the pseudomonads and other 
non-fermentor Gram-negative bacilli (Bryan, L.E. and Van Den Elzen, H.M., 1977; Martin, 
N.L. and Beveridge, T.J., 1986). This mechanism of reduced uptake of the drug is generally 
due to membrane impermeabilization, which impairs drug penetration into the cell (Bryan, L.E. 
and Van Den Elzen, H.M., 1977; Davis, B.D., 1987) and results in an intermediate 
susceptibility to all of the aminoglycosides (Miller, G.H., et al, 1997; Lister, P.D., 2002). In 
addition, adaptive resistance to aminoglycosides is often reported for aerobic Gram-negative 
bacilli, such as Pseudomonas spp. (Davis, B.D., 1987; Wright, G.D., et al, 1998). This 
resistance is thought to be due to regulatory events rather than mutations or the acquisition of 
resistance genes, so it does not persist once the selective pressure is removed (Karlowsky, J.A., 
et al, 1996). We do not discount the possibility that this mechanism may contribute to the 
multiple drug resistance phenotypes displayed by the non-fermenting organisms identified in 
this study (Chapters 2 and 3). This could act in synergy with the expression of the resistance 
gene aac(3)IIa detected in the majority of these organisms.  
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Another mechanism of reduced accumulation of an antibiotic within the bacterial cell is 
through the active efflux or pumping of the drug out of the cell (Zgurskaya, H.I. and Nikaido, 
H., 2000), which is more frequently observed in non-fermentor Gram-negative bacilli (Martin, 
N.L. and Beveridge, T.J., 1986; Westbrock-Wadman, S., et al, 1999), but has also been 
reported in Samonella spp. and E. coli (Nikaido, H., et al, 1998; Rosenberg, E.Y., et al, 2000). 
Multidrug efflux pumps can be acquired as foreign genes, or alternatively, the reduced 
accumulation of an antibiotic can be due to the activation or the increased expression of an 
innate efflux system (Westbrock-Wadman, S., et al, 1999; Putman, M., et al, 2000; Zgurskaya, 
H.I. and Nikaido, H., 2000; Lister, P.D., 2002). Although multidrug efflux pumps generally 
have low substrate specificities (Zgurskaya, H.I. and Nikaido, H., 2000), some studies have 
reported efflux pumps that pump aminoglycosides out of the cell (Aires, J.R., et al, 1999; 
Rosenberg, E.Y., et al, 2000; Mao, W., et al, 2001). Furthermore, the presence of different 
efflux pumps may confer additive or multiplicative effects on drug resistance (Lee, A., et al, 
2000).  
In this study, it is improbable that the high-level gentamicin resistance observed in 
bacteria other than non-fermentors is due to the activation of innate efflux pumps, since this 
phenotype was transferable through conjugation and transformation, suggesting the genes are 
plasmid-borne. It is possible that this mechanism can account for the multiple antibiotic 
resistance phenotypes observed in the non-fermenting organisms, but further studies are 
necessary to ascertain such information. While in this study we did not detect (Chapter 2) a 
plasmid-encoded efflux pump which could be transferred among the organisms in the turtle 
farm environment, this possibility is not entirely discarded and should be tested in the future 
using aminoglycoside accumulation assays.  
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By far the most important mechanism of aminoglycoside resistance is the enzymatic 
modification of the drug by aminoglycoside modifying enzymes, resulting in a molecule with 
decreased binding affinity to the ribosome (Wright, G.D., et al, 1998; Vakulenko, S.B. and 
Mobashery, S., 2003). The largest group of these enzymes, the aminoglycoside 
acetyltransferases, participate in the acetylCoA-dependent acetylation of specific 
aminoglycoside amino groups (Shaw, K.J., et al, 1993; Wright, G.D., et al, 1998; Azucena, E. 
and Mobashery, S., 2001; Vakulenko, S.B. and Mobashery, S., 2003). Aminoglycoside 
modifying enzymes display substrate specificity, which means that each enzyme will modify a 
specific chemical group, resulting in a particular phenotype (Shaw, K.J., et al, 1993; Wright, 
G.D., et al, 1998).  
According to the nomenclature proposed by K.J. Shaw et al, (Shaw, K.J., et al, 1993), 
AAC(3)IIa is an acetyltransferase enzyme which participates in the addition of an acetyl group 
to the amino group at position 3 of the 2-deoxystreptamine ring of the aminoglycoside 
molecule, giving resistance profile “II” by gene a (Shaw, K.J., et al, 1993; van de Klundert, 
J.A. and Vliegenthart, J.S., 1993; Wright, G.D., et al, 1998; Vakulenko, S.B. and Mobashery, 
S., 2003). Enzyme AAC(3)VIa uses the acetyl group from an acetyl coenzyme-A donor 
molecule to modify the aminoglycoside molecule at the position 3 of the 2-deoxystreptamine 
ring, and confers resistance profile VI, by gene a (Shaw, K.J., et al, 1993; Vakulenko, S.B. and 
Mobashery, S., 2003).  
The AAC(3)-II resistance pattern phenotype reportedly involves resistance to 
gentamicin, tobramycin, sisomicin, netilmicin, and dibekacin (Shaw, K.J., et al, 1993; Miller, 
G.H., et al, 1997; Vakulenko, S.B. and Mobashery, S., 2003) whereas AAC(3)-VI includes 
resistance to gentamicin (Shaw, K.J., et al, 1993; Miller, G.H., et al, 1997; Diaz, M.A., et al, 
2000; Diaz, M.A., et al, 2001; Vakulenko, S.B. and Mobashery, S., 2003). Though each 
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aminoglycoside modifying enzyme presents substrate specificity, the antibiotic resistance 
phenotype alone cannot be used in a study to determine the gene confering this resistance since 
there may be cumulative effects from multiple enzymes (Shaw, K.J., et al, 1993; Miller, G.H., 
et al, 1997). Thus, in this study, the problem was approached by cloning and sequencing of the 
genes which conferred gentamicin resistance to bacteria isolated at the turtle farms and which 
were transfered by conjugation and transformation to naïve E.coli. As discussed in Chapter 2, 
these experiments lead to the identification of genes aac(3)IIa and aac(3)VIa (Diaz, M.A., et 
al, in press). 
The gene aac(3)IIa was originally identified in R-plasmids in Enterobacteraceae 
(Allmansberger, R., et al, 1985), as well as aac(3)VI, originally cloned from a conjugative 
plasmid of Enterobacter cloacae. The enzymes encoded by these genes reportedly share 50% 
amino acid identity (Rather, P.N., et al, 1993; Vakulenko, S.B. and Mobashery, S., 2003). In 
effect, all gentamicin resistant organisms tested in this study were positive for either one of the 
two aac(3) genes detected in the cloning and sequencing of gentamicin resistance determinants. 
These genes were detected in quite diverse organisms from the turtle farms, which were also 
different from the organisms originally reported on (Brau, B., et al, 1984; Allmansberger, R., et 
al, 1985; Rather, P.N., et al, 1993). Furthermore, each of these genes were found to be encoded 
on different plasmids, as shown in Chapter 2, all of which supports their dissemination through 
mobile molecular elements.  
In this regard, it is relevant to state that when we began this study, only gene aac(3)VIa 
had been reported to be encoded as a gene cassette in a class-1 integron (Brau, B., et al, 1984; 
Allmansberger, R., et al, 1985; Rather, P.N., et al, 1992; Rather, P.N., et al, 1993; Diaz, M.A., 
et al, 2000; Diaz, M.A., et al, 2001). Integrons are gene-capture molecular elements that 
contain an integrase gene, named intI, and an arrangement of gene cassettes which are 
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expressed from a common promoter (Stokes, H.W. and Hall, R.M., 1989; Collis, C.M. and 
Hall, R.M., 1995) and which are often found on the plasmids and/or the chromosomes of 
Gram-negative bacteria (Hall, R.M. and Stokes, H.W., 1993; Recchia, G.D. and Hall, R.M., 
1997; Fluit, A.C. and Schmitz, F.J., 1999; Hall, R.M., et al, 1999; Rowe-Magnus, D.A. and 
Mazel, D., 1999; White, P.A., et al, 2001). The majority of gene cassettes described to date 
code for antibiotic resistance (Fluit, A.C. and Schmitz, F.J., 1999; Fluit, A.C. and Schmitz, F.J., 
2004) and are thus known as multiple resistance integrons or MRIs. (Recchia, G.D. and Hall, 
R.M., 1995; Fluit, A.C. and Schmitz, F.J., 1999; Mazel, D. and Davies, J., 1999). 
Four different classes of integrons had been identified before 2001, according to the IntI 
integrase and the general gene arrangement that they encode, namely, class-1 (Stokes, H.W. 
and Hall, R.M., 1989), class-2, class-3 (Collis, C.M., et al, 2002) and class-4 (Mazel, D., et al, 
1998). The main distinguishing features of integron classes, other than class-1, are summarized 
in Table 5.4. In this study, we detected the presence of the integrase gene of integron class-1 
associated with the gene aac(3)VIa. In effect, all isolates carrying this gene were also positive 
by PCR to intI1 (Chapter 2). However, isolates carrying aac(3)IIa were not intI1-positive by 
this assay, with the primer set described in Chapter 2.  
The larger type of integrons, referred to as “super-integrons” or SIs and originally 
described in Vibrio cholerae (Mazel, D., et al, 1998; Rowe-Magnus, D.A., et al, 1999; Rowe-
Magnus, D.A. and Mazel, D., 1999; Clark, C.A., et al, 2000) are also found as components of 
the genomes of many γ-proteobacteria, such as Xanthomonas spp., Shewanella spp. and 
Pseudomonas spp. (Rowe-Magnus, D.A., et al, 1999; Rowe-Magnus, D.A. and Mazel, D., 
1999; Vaisvila, R., et al, 2001). On the other hand, though the sequences which flank gene 
cassettes can vary greatly between different integron classes (Hall, R.M., et al, 1994; Stokes, 
H.W., et al, 1997; Stokes, H.W., et al, 2001), identical gene cassettes have been found to be 
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Table 5.4.  General Characteristics of Integrons Class II, III and IV 
 
Class II Class III Class IV Other classes 
- Included in the family of 
Tn7 transposons  
- Presence of Tn7 
transposition genes 
 
- Only one described to date 
 
- Super-integron (SI) or 
‘integron island’  
- First described in Vibrio 
cholerae 
- Only the integrases 
detected, from 
environmental DNA 
- a defective integrase gene 
intI2, located at 5’CS 
 
- Integrase gene intI3 has 
61% homology with intI1 
- Integrase gene intI4 
 
- intI5, intI6, intI7 … 
- 3 integrated gene cassettes: 
dhfrI-sat-aadA1 
- No sulI gene 
 
- contains gene cassette 
blaIMP  
- Presence of a part of gene 
aacA4 
- ~ 100 gene cassettes 
- gene cassettes encoded 
may have virulence 
functions (not antibiotic 
resistance) 
 
- att site located between 
gene intI2 and 1st 
resistance gene, as in class 
I integrons.  
- Atypical recombination 
sites around gene cassette 
  
 
 
 
encoded in integrons of different classes, which indicates that the gene cassette pool may be 
shared between them (Fluit, A.C. and Schmitz, F.J., 1999; Rowe-Magnus, D.A. and Mazel, D., 
1999; Rowe-Magnus, D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz, F.J., 2004).  
In this study, we detected the presence of aac(3)IIa in different plasmids and diverse 
bacterial genera of organism, so it was hypothesized that the gene was encoded within a mobile 
molecular element such as another integron besides class-1, possibly even a superintegron as 
described in Xanthomonas spp., and Pseudomonas spp. (Rowe-Magnus, D.A., et al, 1999; 
Rowe-Magnus, D.A. and Mazel, D., 1999; Vaisvila, R., et al, 2001). For this reason we 
screened for the presence of putative integrase (Nield, B.S., et al, 2001) and gene cassette 
(Stokes, H.W., et al, 2001) genes, using degenerate primers designed to detect these elements 
in DNA from environmental bacteria (Nield, B.S., et al, 2001; Stokes, H.W., et al, 2001). 
These assays, though numerous and quite extensive (Diaz, M.A., et al, 2002b; Diaz, M.A., et 
al, 2002a), did not lead to detection of an integrase or gene cassette from the isolates studied. 
Thus, this screening strategy which proved useful in detecting new integrases and gene 
cassettes from the environment in Australia (Stokes, H.W., et al, 2001), was quite unfruitful in 
this study, as well as others (J. Davies, personal communication). Nevertheless, this approach 
and others which involve the molecular screening for antibiotic resistance genes is important 
and should be pursued, as many of the organisms that help maintain antibiotic resistance gene 
pools are not necessarily cultivable, and thus escape detection through classic antimicrobial 
testing, as seen in Chapter 3 . 
Class-1 integrons are the most prevalent integrons among clinical isolates (Hall, R.M. 
and Stokes, H.W., 1993; Fluit, A.C. and Schmitz, F.J., 1999). Their basic structure is 
characterized by the presence of two conserved sequences, known as the 5’-CS and 3’-CS, 
which flank a variable region. The 5'-conserved region contains the integrase gene intI1 and a 
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gene cassette attachment site, attI. The 3'-conserved region is characterized by the presence of a 
sulfonamide resistance gene, sul1, a quaternary ammonium compound resistance gene, qacE∆1 
and open reading frames orf5 and orf6, with unknown functions (Stokes, H.W. and Hall, R.M., 
1989; Hall, R.M. and Stokes, H.W., 1993). These conserved regions have proven useful to 
design primers that allow the detection of gene cassette arrangements encoded within the 
variable region of class-1 integrons (Levesque, C., et al, 1995; Sandvang, D., et al, 1997). This 
variable region of class-1 integrons can code for one or more gene cassettes (Stokes, H.W. and 
Hall, R.M., 1989; Hall, R.M. and Stokes, H.W., 1993). In this study, we used these published 
5’CS-3’CS primers (Sandvang, D., et al, 1997) to screen for the presence of different gene 
arrays in the isolates under study. This lead to the detection of the expected gene cassettes from 
organisms known to be carrying gene aac(3)VIa within a class-1 integron, but interestingly, we 
also obtained amplicons for organisms which had been negative for intI1 (Chapter 2) and which 
carried gene aac(3)IIa.  
Gene cassettes can be exchanged between the different integron classes, which supports 
the notion that they may have played an important role in bacterial evolution (Rowe-Magnus, 
D.A. and Mazel, D., 1999; Rowe-Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, 
D., 2001; Rowe-Magnus, D.A., et al, 2002; Holmes, A.J., et al, 2003). In effect, the genetic 
flexibility that integrons confer bacteria allows them to adapt rapidly to environmental 
challenges by allowing bacteria to acquire favorable genes that can result in an improved 
fitness as well as eliminate those that prove useless (Hall, R.M., et al, 1999; Rowe-Magnus, 
D.A. and Mazel, D., 1999; Rowe-Magnus, D.A. and Mazel, D., 2001; Fluit, A.C. and Schmitz, 
F.J., 2004). On the other hand, even though the majority of the cassettes in the SIs are not 
expressed, they are believed to be maintained in the absence of selective pressure as a genetic 
resource for the evolution of new genes (Rowe-Magnus, D.A. and Mazel, D., 1999; Rowe-
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Magnus, D.A., et al, 2001; Rowe-Magnus, D.A. and Mazel, D., 2001; Rowe-Magnus, D.A., et 
al, 2002; Holmes, A.J., et al, 2003).  
There is great variability in the level of expression of genes encoded as gene cassettes. 
This can be due to intrinsic characteristics of both the gene cassettes and the integron 
(Levesque, C., et al, 1994; Collis, C.M. and Hall, R.M., 1995; Hall, R.M. and Collis, C.M., 
1995; Recchia, G.D. and Hall, R.M., 1995). Gene cassettes are inserted in integrons in the same 
orientation to their coding sequence, with their initiation codons located near their 5’ end (Hall, 
R.M. and Collis, C.M., 1995). Generally, gene cassettes do not code a promoter of their own, 
but are rather expressed from a common promoter, Pant or P1, or rarely from P2 (Levesque, C., 
et al, 1994; Collis, C.M. and Hall, R.M., 1995; Stokes, H.W., et al, 2001). Both P1 and P2 
promoters are located in the 5’-conserved segment (5’-CS) of class 1 integrons. P1 is located in 
a region 200 bp upstream from the genes-cassettes inserted at the attI1 site (Levesque, C., et al, 
1994; Collis, C.M. and Hall, R.M., 1995).  
Several factors can affect the expression of the gene cassettes in an integron (Ploy, 
M.C., et al, 2000). The P1 promoter sequence has strong sequence similarity to the E. coli 
promoter consensus sequence. Studies on integron promoter sequences support that variations 
in the sequence of P1 can significantly affect the level of expression of a given gene (Levesque, 
C., et al, 1994; Collis, C.M. and Hall, R.M., 1995). In this study, we did not detect any 
mutation which could have an effect on the expression of the gentamicin resistance gene 
cassettes.  
Another factor which can significantly affect the expression of gene cassettes is the 
order in which the cassette is inserted in the integron. Thus, the level of resistance conferred is 
higher for the resistance genes that are located in the first place, i.e. the first cassette. Likewise, 
it is reduced when there are preceding cassettes (Levesque, C., et al, 1994; Collis, C.M. and 
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Hall, R.M., 1995; Ploy, M.C., et al, 2000). In this sense, it is not surprising to have found in 
this study gene aac(3)VIa to be in the first position in the array of gene cassettes, near the 
integrase gene.  
As stated before, when we began this study, only the gene aac(3)VIa had been reported 
as a gene cassette within a class-1 integron. In our preliminary work, we had detected integron 
elements in bacteria carrying the aac(3)IIa gene as well (Diaz, M.A., et al, 2002b; Diaz, M.A., 
et al, 2002a; Diaz, M.A., et al, in press). However, recent studies by others have also depicted 
the aac(3)II gene to be surrounded by integron elements (Galimand, M., et al, 2003). In fact, 
the molecular environment of the armA gene has been depicted as a composite or complex 
class 1 integron environment (Partridge, S.R. and Hall, R.M., 2003). Complex class 1 
integrons, as the classical class 1 integrons, possess a 5’-conserved sequence (5’-CS) encoding 
an integrase gene and a gene cassette attachment site, attI. The variable sequence can encode 
one or more resistance gene cassettes. Then, instead of a single 3’-conserved sequence, there 
are two 3’-conserved sequences: 3’-CS1 and 3’-CS2, both of which encode quaternary 
ammonium compound gene qacE∆1 and sul1. The 3’-CSs are spanning a conserved region, 
CR, and a unique region. The CR typically encodes orf513, encoding a putative recombinase, 
and a potential recombination site. The unique region generally encodes resistance genes, 
which are not encoded as gene cassettes. The general structure of complex integrons is 
presented in Figure 5.3 (Partridge, S.R. and Hall, R.M., 2003; Doublet, B., 2004). 
This type of arrangement has been described in other organisms, involving a mobile 
integrative structure known as a conjugative transposon (Salyers, A.A., et al, 1995; Partridge, 
S.R. and Hall, R.M., 2003), which could further contribute to its dissemination. Conjugative 
transposons are DNA elements that can excise themselves to form a covalently closed circular 
intermediate (Salyers, A.A., et al, 1995). This intermediate can then reintegrate itself within the 
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same organism or, it can be transfered by conjugation to a recipient cell and then integrate in 
the recipient’s genome (Salyers, A.A., et al, 1995; Pembroke, J.T., et al, 2002; Partridge, S.R. 
and Hall, R.M., 2003). First found in Gram-positive bacteria such as the streptococci and 
enterococci (Tolmasky, M.E., 2000) and barely mentioned before 1996 in Gram-negative 
bacteria (Pembroke, J.T., et al, 2002), conjugative transposon-like elements have later been 
detected in Gram-negative bacteria such as Bacteroides spp. (Salyers, A.A., et al, 1995; 
Pembroke, J.T., et al, 2002) and though characterized in a lesser extent, in the 
Enterobacteriaceae. They have been reported in Salmonella spp., Proteus spp., in the SXT 
element in Vibrio spp. and in the element known as R391 (Salyers, A.A., et al, 1995; 
Pembroke, J.T., et al, 2002; Partridge, S.R. and Hall, R.M., 2003).  
Because the aac(3)IIa gene product was not reported to confer high-level gentamicin 
resistance, we hypothesized in the first stages of our studies that we would find a second gene 
which could act in synergy with the already identified genes to confer high-level gentamicin 
resistance to several members of the Enterobacteriaceae that we had isolated in our 
laboratories and which displayed the HLGR phenotype (Diaz, M.A., et al, 2000; Diaz, M.A., et 
al, in press). We redirected our study following a recent report that high-level aminoglycoside 
resistance in a clinical strain of Klebsiella pneumoniae was due to the presence of armA, a new 
aminoglycoside resistance methylase gene with only 37-47% similarity to the 16S rRNA 
methyltransferases from actinomycetes (Galimand, M., et al, 2003). This strain also presented 
genes aac(3)II, blaTEM1, blaCTX-M, dfrA12, sul1 and ant(3")9, conferring resistance to 
aminoglycosides, β-lactams, trimethroprim, sulfonamides and streptomycin-spectinomycin, 
respectively. Other genes conferring high-level aminoglycoside resistance in Gram-negative 
bacteria have been found in a Japanese clinical isolate of Pseudomonas aeruginosa AR-2 
(Yokoyama, K., et al, 2003) and Serratia marcescens (Doi, Y., et al, 2004), namely, methylase 
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enzymes rmtA and rmtB (Doi, Y., et al, 2004; Yamane, K., et al, 2005). The GC content of 
these genes and functional analysis of these enzymes support a possible horizontal gene 
transfer from aminoglycoside-producing microorganisms (Yokoyama, K., et al, 2003; Doi, Y., 
et al, 2004; Yamane, K., et al, 2005). In this study, in spite of quite numerous PCR, cloning and 
sequencing assays performed with the aim of identifying any of these methylase enzymes in the 
isolates obtained from the turtle farm environment, we did not obtain any amplicon which, 
upon its sequencing, confirmed the presence of any of these methylase-encoding genes in our 
isolates.  
Interestingly, when we screened for other genes associated with the reported methylase 
genes (Galimand, M., et al, 2003; Galimand, M., et al, 2005), we obtained amplification of the 
intI1 gene for isolates containing gene aac(3)IIa. As mentioned before, this is in contradiction 
with what we had obtained using a different primer set, mentioned in Chapter 2. It is then 
possible that gene aac(3)IIa is carried by a complex integron and thus was not detected as such 
with the primer pair used to detect the classic structure of integron class-1. The general 
structure of complex integrons is illustrated in Figure 5.3 (Partridge, S.R. and Hall, R.M., 
2003; Doublet, B., 2004). Sequencing of regions encoding gene cassettes will shed light in this 
regard (Chapter 4) (Levesque, C., et al, 1995; Sandvang, D., et al, 1997; Sunde, M. and Sorum, 
H., 1999; Nield, B.S., et al, 2004). Interestingly, recent investigations have found integron-
encoded ribosomal methylase genes (Nield, B.S., et al, 2004). 
In conclusion, there are two genes which contribute to the high-level gentamicin 
resistance in bacteria isolated from sites with turtle farming activity in Louisiana. These genes 
are aac(3)IIa and aac(3)VIa, which code for aminoglycoside acetyl-transferase enzymes. These 
confer resistance to various aminoglycosides and were detected on different conjugative 
plasmids. The resistance genes detected in bacteria recovered from environmental samples with 
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turtle farming activity are coded on class-1 integrons . The molecular environment differed 
amongst the diverse isolates, which supports their presence on molecular gene exchange 
elements. Thus, transfer of these genes may involve a complex class-1 integron. Further studies 
of their molecular environment are required in order to detect and characterize such mobile 
structures. 
This work constitutes one of the first reports of high-level gentamicin resistance in 
Gram-negative bacteria. It is one of the first to report aminoglycoside resistance genes 
aac(3)IIa and aac(3)VIa in environmental isolates of Salmonella enterica subsp. arizonae. 
Additionally, this study illustrates the potential of transfer of antibiotic resistance genes, 
particularly gentamicin resistance, among bacteria in an environment with turtle farming 
activity, a matter of particular concern as it involves the human pathogen Salmonella spp. This 
research provides epidemiological data of resistance to aminoglycosides currently used both in 
the turtle farms and in the clinical setting. The data presented highlights the current inefficacy 
of the antibiotic gentamicin to eradicate Salmonella spp. from turtle eggs. We hope to persuade 
the relevant authorities in Louisiana to revise the mandate of using gentamicin for turtle egg 
treatment, and to stress the need to develop new treatments to eradicate Salmonella spp. from 
turtle hatchlings.  
This work does not undermine the value of antibiotic use. It does, however, intend to 
emphasize the importance of monitoring the inevitable emergence of antibiotic resistance, so its 
appropriate implementation can be redirected accordingly. It is a process in flux, far from being 
static, which involves continuous vigilance, and surveillance. Ultimately, one of the solutions 
with the highest impact on antibiotic resistance is the adequate education of people who use 
them, at any level.  
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Real-time PCR, also referred to as Q-PCR, is a variation of the PCR assay in which the 
exact amount of PCR amplification products can be monitored as it is being made. This is in 
part due to the properties of the fluorescent molecules used to track these products. One of 
these molecules, SyberGreen, binds to DNA with much higher affinity for double-stranded than 
single-stranded DNA. In addition, when bound to double-stranded DNA, SyberGreen 
fluoresces, which is detected by the spectrophotometer built into the thermocycler, thus 
monitoring the formation of PCR product as it is being made, or in real time.  
In this study, real-time PCR was standardized to detect gene aac(3)IIa. Primers 
designed within conserved sequences of the rrn gene were used to amplify part of the 
ribosomal gene as a control or reference (Chapter 2). The primers used to amplify gene 
aac(3)IIa were designed using the Beacon Designer 2.0 software (Biosoft International, Palo 
Alto, CA). Genomic DNA used for all reactions was obtained from a strain of Salmonella 
enterica subsp. enterica which was positive by conventional PCR and sequencing to gene 
aac(3)IIa (Chapter 2).  
The figures included in this Appendix show the suitability of all primers designed to 
amplify genes aac(3)IIa and rrn. SybrGreen (SYBR-490) was used as the fluorescein molecule 
to track the real-time progression of all Q-PCR reactions. Figure A.1., Figure A.4., and Figure 
A.6. show the melting curve graphs for genes aac(3)IIa and rrn using SYBR-490. It is evident 
from these figures that the primer sets designed produce only one amplicon in each case. In 
effect, melting points for aac(3)IIa gene amplicons are all at 86oC and those for rrn gene 
amplicons are all at 88oC. Two much smaller curves, in blue and red, which peak around 
82.5oC, correspond to the primer controls in which no DNA was added, and evidence the 
suitability of primers designed for real-time PCR.  
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Figure A.5. and Figure A.7. present results from real-time PCR graphs for genes 
aac(3)IIa and rrn, as obtained by using SYBR-490. These graphs show the logarithmic plot of 
real-time PCR through all cycles. The CT values can be seen intersecting the orange horizontal 
line, which was set at a point where all PCR reactions were linear. From these graphs, it is 
evident that different DNA concentrations intersect the horizontal line after different amounts 
of cycles, as is expected. Thus, the more diluted the sample, the more cycles it takes to reach a 
certain product quantity. In addition, all replicas intersect the horizontal line at the same 
number of cycles. Furthermore, primer controls, where no DNA was added, can be seen to the 
far right in red and blue, and show that no significant amplification is detected throughout PCR 
cycles. Thus, this is an accurate measurement of the amount of aac(3)IIa and rrn amplicons in 
a particular sample.  
Standard curves were done with 1:10 serial dilutions of Genomic DNA. Figure A.2. 
and Figure A.3. show the standard curves obtained when plotting SYBR-490 values with the 
dilutions of the DNA assayed, throughout the progression of PCR cycles. The high correlation 
coefficients obtained in both curves indicate that both primer pairs designed can be 
appropriately used for the quantitation of gene aac(3)IIa from unknown samples. Because the 
amount of gene rrn does not vary within a particular bacterial strain, differences in rrn 
quantities will account for any variation due to experimental manipulation or error. Thus, it can 
be used as a reference to compare against variations in aac(3)IIa amounts. With this 
methodology, variations in the number of aac(3)IIa, following exposure to different treatments, 
could be measured. Furthermore, the expression of this gene could also be monitored, using 
these same primers and conditions, but using total bacterial cDNA as template DNA. This 
Appendix includes data from experiments unfinished as of yet and which will be published as a 
communication of a technique standardization. 
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Figure A.1.   Melt Curve Graph for Genes aac(3)IIa and rrn, Using SYBR-490 
 
 
Figure A.2.   Standard Curve Graph for Gene aac(3)IIa, Using SYBR-490 
 
 
Figure A.3.   Standard Curve Graph for Gene rrn, Using SYBR-490
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Figure A.4.   Melt Curve Graph for Gene aac(3)IIa, Using SYBR-490 
 
 
 
Figure A.5.   Real Time PCR Graph for Gene aac(3)IIa, Using SYBR-490 
 149
  
Figure A.6.   Melt Curve Graph for Gene rrn, Using SYBR-490 
 
 
 
Figure A.7.   Real Time PCR Graph for Gene rrn, Using SYBR-490 
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